| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | AB | AC | AD | AE | AF | AG | AH | AI | AJ | AK | AL | AM | AN | AO | AP | AQ | AR | AS | AT | AU | AV | AW | AX | AY | AZ | BA | BB | BC | BD | BE | BF | BG | BH | BI | BJ | BK | BL | BM | BN | BO | BP | BQ | BR | BS | BT | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Paper Number | Title of Paper | Author Information | Year Started-Year Ended/ Ongoing | Cohort Information | Funding | Study Specifications | Number of | Participants | Demographic | characteristics | Hearing Loss Data | Hearing | data | Other Investigations | Genetic Test Type | Name of Specific gene(s) studied | Medical Condition(s) in Genotyped Data | Year of genetic analysis (if different from date of publication) | Key Study Findings Relevant to Hearing Loss | Any Potential Targets For Therapy Identified in the Study? Yes:1 No:2 | Please specify the identified potential targetrs for therapy if yes | Have Patients Within The Cohort Given Consent To Be Contacted? Yes:1 No:2 Unkown: 0 | Which I.T. System/Software Is Used To Manage The Database? (if specified) | ||||||||||||||||||||||||||||||||||||||||||||||||
2 | Names of Authors | Corresponding Author Contact | Name of Cohort used (if any) | Name of the paper's target disease/hearing type | Country/Region of Cohort | Cohort type/target | Study Design Prospective:1 Retrospective:2 Registry:3 Other:4 | Please specify if other | Study Type Basic Science: 1 Clinical:2 | Number of participants in the study | Number of participants in the Cohort (if different) | Age | Age range | Gender Both: 1 Female: 2 Male:3 | Ethnicity | Hearing Loss Laterality Unilateral:1 Bilateral:2 Both: 3 Unspecified:0 | Underlying diagnosis Glue ear: 1 Cholesteatoma: 2 ARHL: 3 SSNHL: 4 NIHL: 5 Other:6 Unspecified: 0 | Please specify underlying disease if other | PTA Yes:1 No:2 | Speech in Noise Yes:1 No:2 | ABR Yes:1 No:2 | OAEs Yes:1 No:2 | Tympanometry Yes:1 No:2 | Other hearing tests / Other comments | Cognitive Function Assessments Yes:1 No:2 | Please specify cognitive function assessments used, if yes | Imaging Studies Yes:1 No:2 | Please specify imaging studies used, if yes | Serum Biomarkers e.g. Prestin Yes:1 No:2 | Please specify serum biomarkers used, if yes | Electrophysiological tests Yes:1 No:2 | Please specify electrophysiological tests used, if yes | Cardiovascular measures Yes:1 No:2 | Please specify cardiovascular measures used, if yes | Other Other investigations / Other comments | GenomeWide Association Study Yes:1 No:2 | Whole Exome Sequencing Yes:1 No:2 | Gene Panel Sequencing Yes:2 No:2 | Single Gene Sequencing Yes:1 No:2 | Other Test (Please specify) | ||||||||||||||||||||||||||||||||
3 | 43 | Recent Epidemiology of Pediatric Cochlear Implantation in the United States: Disparity Among Children of Different Ethnicity and Socioeconomic Status | R E Stern, B Yueh, C Lewis, S Norton, K C Y Sie | restern@u.washington.edu | 1997 | 1. Washington 1997 Health Care and Utilization Project/Kids’ Inpatient Database 2. 2000 Galludet Research Institution (GRI) national demographic study | SNHL - undifferentiated | North America | SNHL - Undifferentiated | Retrospective: 2 | Clinical : 2 | 124 | (database updated annually) | 0-18 | Both: 1 | White, Asian, Hispanic, Black | SNHL: 1 | White and Asian pediatric patients received cochlear implants at proportionally higher rates than blacks and Hispanic pediatric patients, even after adjustment for the prevalence rates of severe to profound SNHL in each racial and ethnic group. | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | 221 | Factors Associated With Hearing Impairment in Patients With Congenital Hypothyroidism Treated Since the Neonatal Period: A National Population-Based Study | L Lichtenberger-Geslin, S Dos Santos, Y Hassani, E Ecosse, T Van Den Abbeele, J Léger | juliane.leger@rdb.aphp.fr | 1. 1978 - 1988, 2. 2003 | 1. Cohort of congenital hypothyroidism, 2. Decennial Health Survey | SNHL - Genetic | France | Other disease registries/cohorts | French Ministry of Health (Programme Hospitalier de Recherche Clinique AOM 05011), Pfizer Foundation for Children and Adolescents | Prospective: 1 | Clinical : 2 | 1,162 | 1842 | 24.5 | 18-23,5++ | Both: 1 | Both:3 | Other:6 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | Yes:1 | RRM2B | Ophthalmoparesis, Ptosis, Proximal muscle weakness, Bulbar dysfunction, Ataxia, Fatigue, Sensorineural hearing loss, Endocrinopathy, Gastrointestinal disturbance, Cognitive impairment/learning difficulties, Encephalopathy/stroke-like episodes, Renal disturbance, Depression, Neuropathy, Pigmented retinopathy, Cardiac dysfunction/arrhythmia, Cataracts, Migraine, Distal muscle weakness, Glaucoma, Short stature | Hearing loss was associated with the type of congenital hypothyroidism, with disease severity, and with other associated chronic diseases | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||
5 | 251 | Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics | RDS Pitceathly, C Smith,C Fratter,CL Alston,L He, K Craig, EL Blakely, JC Evans, J Taylor,Z Shabbir,M Deschauer,U Pohl, ME Roberts, MC Jackson,CA Halfpenny, PD Turnpenny, PW Lunt, MG Hanna, AM Schaefer,R McFarland,R Horvath, PF Chinnery, DM Turnbull, J Poulton, RW Taylor and GS Gorman | grainne.gorman@ncl.ac.uk | Dates unspecified | 1. Newcastle–Oxford–Halle, 2. Additional - systematic review of all previously published cases of RRM2B mutations (2012) | SNHL - Genetic | UK | Other disease registries/cohorts | MRC Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort (UK) (G0800674); Wellcome Trust Centre for Mitochondrial Research (906919); MRC Centre for Neuromuscular Diseases (G0601943); Newcastle University Centre for Brain Ageing and Vitality supported by BBSRC, EPSRC, ESRC and MRC (G0700718); Wellcome Trust Programme Grant (074454/Z/04/Z); UK NIHR Biomedical Research Centre for Ageing and Age-related disease award to the Newcastle upon Tyne Foundation Hospitals NHS Trust. | Prospective: 1 | Basic Science: 1 | 26 | mean 40 yrs | 0-70 | Both: 1 | Unspecified:0 | SSNHL: 4 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | Yes:1 | CIAS1 | Cryopyrin-associated periodic syndromes | Mutations in the nuclear-encoded mitochondrial maintenance gene RRM2B are associated with sensorineural hearing loss | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||
6 | 271 | Cryopyrin-Associated Periodic Syndromes: Otolaryngologic and Audiologic Manifestations | Neda Ahmadi, Carmen C. Brewer, , Christopher Zalewski, Kelly A. King, John A. Butman, Nicole Plass, Cailin Henderson, Raphaela Goldbach-Mansky, H. Jeffrey Kim | H. Jeffrey Kim, MD, Department of Otolaryngology–HNS, Gorman 1, 3800 Reservoir Rd, NW, Washington, DC 20007, USA hk7@gunet.georgetown.edu | 2003 - 2009 | 1. NOMID/anakinra (03-AR0298), a natural history study (03-AR-0173), 2. FCAS/interleukin-1 Trap (05-AR-0014). | Cryopyrin-associated periodic syndromes (CAPS) | Bethesda, Maryland, US | Other disease registries/cohorts | sponsored by the intramural research programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Institute on Deafness and Other Communication Disorders at the NIH. | Prospective: 1 | Clinical : 2 | 57 | 1-69 | Both: 1 | Unspecified:0 | Other:6 | CHL, SNHL, MHL | Yes:1 | Yes:1 | Acoustic reflex | Yes:1 | Inner Ear and Brain FLAIR-MRI | No:2 | Lumbar puncture for patients with CNS symptoms | Hearing loss, especially sensorineural, is one of the most common phenotypic features in CAPS, and it can be progressive. Treatment of CAPS with IL-1 antagonists such as anakinra has been promising, and further studies are needed to determine the effectivenessof IL-1 antagonists in preventing, stabilizing, or even reversing cochlear damage and HL | Yes:1 | IL-1 antagonists for patients wirt CAPS and hearing loss | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||
7 | 183 | A Prospective Investigation of Dietary Intake and Functional Impairments Among the Elderly | J Zhu, Y-B Xiang, H Cai, H Li, Y-T Gao, W Zheng and X-O Shu | xiao-ou.shu@vanderbilt.edu | 1. 2012-2015 2. 1996-2015 | 1. Shanghai Men’s Health Study 2. Shanghai Women’s Health Study | SNHL - ARHL | China | Population cohort | This work was supported by the US National Institutes of Health (grants UM1 CA182910 and UM1 CA173640). | Prospective: 1 | Clinical : 2 | 74,941 | 18,458 | >70 | Male: 3 | Chinese | Unspecified:0 | No:2 | No:2 | No:2 | No:2 | No:2 | Outcomes for hearing/vision, memory, and decision-making ability were defined as having no, minor, or serious impairments in functional status | Yes:1 | Self reported memory and decision-making ability outcomes | No:2 | No:2 | No:2 | No:2 | Dietary Intake | This study indicates that dietary intake plays an important role in the development of both physical and mental functional impairments among elderly Chinese. Hearing and vision were measured simultaneously in a single question, so that inferences cannot be made for each of them separately | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||
8 | 189 | Associations of obesity and weight change with physical and mental impairments in elderly Chinese people | J Zhu, Y-B Xiang, H Cai, H Li, Y-T Gao, W Zheng and X-O Shu | xiao-ou.shu@vanderbilt.edu | 1. 2012-2015 2. 1996-2015 | 1. Shanghai Men’s Health Study 2. Shanghai Women’s Health Study | SNHL - undifferentiated | China | Population cohort | This work was supported by the National Institutes of Health [UM1 CA173640 and UM1 CA182910]. The study sponsors had no role in the design, methods, subject recruitment, data collection, analysis, or preparation of this paper. | Prospective: 1 | Clinical : 2 | 74,941 | 18,458 | >70 | Male: 3 | Chinese | Unspecified:0 | No:2 | No:2 | No:2 | No:2 | No:2 | Outcomes for hearing/vision, memory, and decision-making ability were defined as having no, minor, or serious impairments in functional status | Yes:1 | Self reported memory and decision-making ability outcomes | No:2 | No:2 | No:2 | No:2 | Dietary Intake, height, weight, and circumferences of waist and hip | Being underweight at middle age (OR = 0.86, 95% CI: 0.76, 0.97) was inversely associated with having minor problems in hearing/vision. Conversely, being underweight (BMI < 18.5) after age 70 (OR = 1.53, 95% CI: 1.29, 1.82) was positively associated with decreased function in hearing or vision. Weight gain from 20 years old to age at baseline was inversely associated with serious impairments in hearing or vision | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||
9 | 246 | Targeted surveillance for postnatal hearing loss: A program evaluation | R Beswick, C Driscoll, J Kei, S Glennon | Rachael_Beswick@health.qld.gov.au | September 2004 - December 2009 | 1. UNHS program, Healthy Hearing, 2. Queensland’s targeted surveillance program | SNHL - undifferentiated | Australia | ALL - Undifferentiated | 1) School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, Queensland, Australia 2) Clinical and State-wide Services, Queensland Health, Queensland Government, Queensland, Australia | Prospective: 1 | Clinical : 2 | 7,320 | 56 | around 34 weeks | Both: 1 | Both:3 | sensorineural, mixed, conductive, auditory neuropathy | Yes:1 | No:2 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | Positive cases of postnatal hearing loss were detected through the targeted surveillance program. | Yes:1 | For targeted surveillance to continue, time frames for assessment, assessments performed, and discharge criteria need to be revisited. | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||
10 | 192 | Dichotic Digits Test Performance Across the Ages: Results From Two Large Epidemiologic Cohort Studies | ME Fischer, KJ Cruickshanks, DM Nindahl, BEK Klein, R Klein, JS Pankow,TS Tweed, DS Dalton and AJ Paulsen | fischer@episense.wisc.edu | 1. 1993 - 2010 2.2005-2008 | 1.Beaver Dam Epidemiology of Hearing Loss Study 2.Beaver Dam Offspring Study (BOSS) | All - undifferentiated | North America | Hearing loss population | The project described was supported by Award Numbers R37AG011099 and R01AG021917 from the National Institute on Aging (to K.J. Cruickshanks), Award Number EY06594 from the National Eye Institute (to R. Klein and B.E.K. Klein), and by unrestricted funds from Research to Prevent Blindness (RPB). | Prospective: 1 | Clinical : 2 | 3655 | 1391 | Both: 1 | Unspecified:0 | ARHL: 3 | Yes:1 | Dichotic Digits Tests | Yes:1 | The Mini-Mental State Examination (MMSE) | Substantial variation in the total free recall DDT scores but very little variation in the right ear directed recall DDT scores was observed. Age, sex, education, hearing loss severity, and cognitive impairment were found to be significantly related to DDT scores but explained less than 25% of the total variability in total free recall scores. The right ear directed recall DDT by itself may not be of benefit in assessing central auditory processing in a general population | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
11 | 281 | The Prevalence of Hearing Impairment and Associated Risk Factors | SD Nash, KJ Cruickshanks, R Klein, BEK Klein, FJ Nieto, GH Huang, JS Pankow and TS Tweed | snash@wisc.edu | 2005 to 2008 | 1.Beaver Dam Epidemiology of Hearing Loss Study 2.Beaver Dam Offspring Study (BOSS) | All - undifferentiated | United States | Hearing loss population | This study was supported in part by R01AG021917 from the National Institute on Aging, the National Eye Institute, and the National Institute on Deafness and Other Communication Disorders. | Prospective: 1 | Clinical : 2 | 3285 | 21-84 | Both: 1 | Both:3 | Unspecified:0 | Yes:1 | Yes:1 | Yes:1 | Yes:1 | Fundoscopy | Yes:1 | Cholesterol, HDL, WBC, Hematocrit | Yes:1 | Systolic and Diastolic Blood Pressure | Hearing impairment is a common condition in middle-aged adults. Cardiovascular disease risk factors may be important correlates of age-related auditory dysfunction | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||
12 | 14 | Dietary Intake of Cholesterol Is Positively Associated and Use of Cholesterol-Lowering Medication Is Negatively Associated with Prevalent Age-Related Hearing Loss | B. Gopinath, V. Flood, E. Teber, C. McMahon, P. Mitchell | paul_mitchell@wmi. usyd.edu.au. | 1997 - 2004 | 1.The Blue Mountains Hearing Study (BMHS) 2. Blue Mountains Eye Study (BMES) | SNHL - ARHL | Australia | Hearing loss population | The BMES was supported by the Australian National Health and Medical Research Council (grants no. 974159, 991407, 211069, and 262120). | Registry: 3 | Clinical : 2 | 2956 | 67 | Both: 1 | Unspecified:0 | SNHL: 1 | Yes:1 | Yes:1 | TG, Serum cholesterol, Dietary cholesterol | Exposure to noisy workplace, Educationa qualifications, History of diabetes, History of diagnosed stroke | A diet high in cholesterol could have adverse influences on hearing, whereas treatment with statins and consumption of monounsaturated fats may have a beneficial influence | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
13 | 18 | The Contribution of Family History to Hearing Loss in an Older Population | C.McMahon, A. Kifley, E. Rochtchina, P. Newall, P.Mitchell | paul_mitchell@wmi.usyd.edu.au | 1992 - 2000 | 1.The Blue Mountains Hearing Study (BMHS) 2. Blue Mountains Eye Study (BMES) | SNHL - Genetic | Australia | Hearing loss population | The BMES was supported by the Australian National Health and Medical Research Council (grants no. 974159, 991407, 211069, and 262120). | Registry: 3 | Clinical : 2 | 2669 | 3654 (BMHS 1) | 67.8 (without FH), 65.9 (with FH). | Both: 1 | Unspecified:0 | ARHL: 3 | Yes:1 | Questionnaire: family history of hearing loss, reported noise exposure at work, history of diabetes, history of stroke, socio-economic status | family history was most strongly associated with moderate to se- vere age-related hearing loss. | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||
14 | 274 | Five-Year Incidence and Progression of Hearing Impairment in an Older Population | Paul Mitchell, Bamini Gopinath, Jie Jin Wang, Catherine M. McMahon, Julie Schneider, Elena Rochtchina, and Stephen R. Leeder | Paul Mitchell, MD, PhD, Centre for Vision Research, University of Sydney, Westmead Hospital, Hawkesbury Road, Westmead, NSW 2145, Australia. paul_mitchell@wmi.usyd.edu.au. | 1997–1999 | 1.The Blue Mountains Hearing Study (BMHS) 2. Blue Mountains Eye Study (BMES) | SNHL - ARHL | Australia | Hearing loss population | The BMES was supported by the Australian National Health and Medical Research Council (grants no. 974159, 991407, 211069, and 262120). | Registry: 3 | Clinical : 2 | 1309 | BMES: 3654 BMHS:2956 | Male: 3 | Unspecified:0 | ARHL: 3 | No:2 | No:2 | No:2 | No:2 | No:2 | Hearing Handicap Inventory for the Elderly-Shortened version | No:2 | No:2 | Yes:1 | Blood glucose, Hg | No:2 | Yes:1 | Blood pressure | Bilateral hearing impairment was an extremely common disability in these older community-dwelling persons. The high frequency of hearing loss in this older population indicates the need to implement programs to reduce or eliminate preventable hearing loss and points to a major public health need | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||
15 | 289 | The Association Between Reduced GFR and Hearing Loss: A Cross-sectional Population-Based Study | E Vilayur, B Gopinath, DC Harris, G Burlutsky, CM McMahon and P Mitchel | paul_mitchell@wmi.usyd.edu.au | 1992-2004 | 1.The Blue Mountains Hearing Study (BMHS) 2. Blue Mountains Eye Study (BMES) | SNHL - undifferentiated | Australia | Hearing loss population | The BMES was supported by the Australian National Health and Medical Research Council (grants no. 974159, 991407, 211069, and 262120). | Prospective: 1 | Clinical : 2 | 2334 | >49 | Both: 1 | Bilateral:2 | Unspecified:0 | Yes:1 | Yes:1 | Yes:1 | Yes:1 | Serum creatinine, Glucose | Yes:1 | Systolic and Diastolic Blood Pressure | BMI, Smoking status, socioeconomic characteristics | Moderate CKD per se was associated independently with hearing loss. Recognizing this link could lead to earlier hearing assessment with appropriate interventions to preserve the hearing of patients with CKD | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||
16 | 291 | Association Between Age-Related Hearing Loss and Stroke in an Older Population | B Gopinath, J Schneider, E Rochtchina, SR Leeder and P Mitchel | paul_mitchell@wmi.usyd.edu.au | 1992 - 2004 | 1.The Blue Mountains Hearing Study (BMHS) 2. Blue Mountains Eye Study (BMES) | SNHL - ARHL | Australia | Hearing loss population | The BMES was supported by the Australian National Health and Medical Research Council (grants no. 974159, 991407, 211069, and 262120). | Prospective: 1 | Clinical : 2 | 2334 | >49 | Both: 1 | Unspecified:0 | ARHL: 3 | Yes:1 | Yes:1 | CT, MRI | BMI, Smoking status, socioeconomic characteristics | observed a strong cross-sectional association between stroke and moderate to severe hearing loss. However, age-related hearing loss did not increase risk of incident stroke in our cohort. Insufficient study power or differing underlying pathologies of sudden sensorineural hearing loss and typical age-related hearing loss may account for the discrepant findings between these studies. | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
17 | 297 | Dietary Glycemic Load Is a Predictor of Age-Related Hearing Loss in Older Adults | B Gopinath, VM Flood, CM McMahon, G Burlutsky, J Brand-Miller and P Mitchel | paul_mitchell@wmi.usyd.edu.au | 1992 - 2004 | 1.The Blue Mountains Hearing Study (BMHS) 2. Blue Mountains Eye Study (BMES) | SNHL - ARHL | Australia | Hearing loss population | The BMES was supported by the Australian National Health and Medical Research Council (grants no. 974159, 991407, 211069, and 262120). | Prospective: 1 | Clinical : 2 | 2956 | >49 | Both: 1 | Bilateral:2 | ARHL: 3 | Yes:1 | Yes:1 | Glucose | Dietary data | Data suggest that high postprandial glycemia might be a potential underlying biological mechanism for age-related hearing loss. | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
18 | 324 | Hearing Impairment and Health-Related Quality of Life: The Blue Mountains Hearing Study | EM Chia, JJ Wang, E Rochtchina, RR Cumming, P Newall, P Mitchell | paul_mitchell@wmi.usyd.edu.au | 1992-2004 | 1.The Blue Mountains Hearing Study (BMHS) 2. Blue Mountains Eye Study (BMES) | SNHL - ARHL | Australia | Hearing loss population | The BMES was supported by the Australian National Health and Medical Research Council (grants no. 974159, 991407, 211069, and 262120). | Prospective: 1 | Clinical : 2 | 2956 | 3654 | 67 | 50 to above 80 | Both: 1 | Both:3 | ARHL: 3 | Yes:1 | No:2 | No:2 | No:2 | No:2 | Air and Bone conduction PTA + self-reported hearing loss | No:2 | No:2 | No:2 | No:2 | No:2 | SF-36 questionnaire | Persons with self-reported hearing loss had significantly poorer HRQOL (Health-Related Quality Of Life) than corresponding persons without, but persons with unilateral or high-frequency hearing loss did not have significantly different HRQOL scores than their corresponding counterparts. | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||
19 | 325 | Mitochondrial DNA Haplogroups and Age-Related Hearing Loss | N Manwaring, MM Jones, JJ Wang, E Rochtchina, C Howard, P Newall, P Mitchell, CM Sue | csue@med.usyd.edu.au | 1992-2004 | 1.The Blue Mountains Hearing Study (BMHS) 2. Blue Mountains Eye Study (BMES) | SNHL - Genetic | Australia | Hearing loss population | The BMES was supported by the Australian National Health and Medical Research Council (grants no. 974159, 991407, 211069, and 262120). | Prospective: 1 | Clinical : 2 | 2765 | 3654 | 50 to above 80 | Both: 1 | Bilateral:2 | ARHL: 3 | Yes:1 | No:2 | No:2 | No:2 | No:2 | Air and Bone conduction PTA + self-reported hearing loss | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | Mitocondrial DNA haplogroups | Findings from this older Australian population demonstrate an association between certain mtDNA haplogroups and ARHL, as well as a link to the susceptibility of other known risk factors for ARHL | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||
20 | 179 | Neuropsychological Test Performance of Cognitively Healthy Centenarians: Normative Data From the Dutch 100-Plus Study | Nina Beker, Sietske A.M. Sikkes, Marc Hulsman, Ben Schmand, Philip Scheltens, Henne Holstege | Henne Holstege, PhD, Alzheimer Center Amsterdam, Department of Neurology, Amsterdam UMC, PO Box 7057, 1007 MB Amsterdam, The Netherlands. h.holstege@vumc.nl | Unspecified | 100-plus Study | SNHL - undifferentiated | Netherlands | Population cohort | Stichting Alzheimer Nederland (WE09.2014-03), Stichting Dioraphte (VSM 14 04 1402), and Stichting VUmc Fond | Other: 4 | case-control | Clinical : 2 | 235 | 306 | >100 | Both: 1 | Unspecified:0 | Unspecified:0 | No:2 | No:2 | No:2 | No:2 | No:2 | No hearing test was done in this study. Hearing was categorized into “good,” “moderate,” “poor,” and “very poor” based on the observations of the study researcher and the self-reported rating of hearing and vision abilities | Yes:1 | Mini-Mental State Examination (MMSE), Dutch Adult Reading Test(DART), The Digit Span, Trail Making Tests A and B (TMT A, TMT B) Controlled Oral Word Association Test, Category fluency, Behavioral Assessment of the Dysexecutive Syndrome Test Battery29 , Rivermead Behavioral Memory Test (RBMT), Visual Association Test (VAT), Number Location subtest of the Visual Object and Space Perception Battery, Clock Drawing Test (CDT) | No:2 | No:2 | No:2 | No:2 | Most of the centenarians retained moderate-good vision (77%) and hearing capacities (88%). Difficulties with vision (41%) and fatigue (22%) were the most common reasons for not being able to complete a test, whereas hearing impairment only rarely complicated test completion (4%). Vision impairments and fatigue complicated test completion, while hearing impairments or task incomprehension rarely did. | No:2 | Unknown: 0 | OpenClinica | |||||||||||||||||||||||||||||||||||||
21 | 17 | A large cohort study of GJB2 mutations in Japanese hearing loss patients | K. Tsukada, S. Nishio, S. Usami, and the Deafness Gene Study Consortium. | usami@shinshu-u.ac.jp | Unspecified | 1000 Japanese hearing loss families | SNHL - Genetic | Japan | SNHL - Genetic/Hereditary | Ministry of Health and Welfare, Japan (S.U.), and a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (S.U.). | Prospective: 1 | Basic Science: 1 | 3056 | Bilateral:2 | SNHL: 1 | Yes:1 | Yes:1 | CT temporal bones | No:2 | Yes:1 | No:2 | No:2 | GJB2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
22 | 334 | 1958 National Child Development Study | Principal Investigator: Alissa Goodman | archive@essex.ac.uk | 1958- | 1958 National Child Development Study | England, Scotland and Wales | Population cohort | Economic and Social Research Council., Medical Research Council, the US National Institutes of Health and the Department for Work and Pensions | Other: 4 | Cohort | Clinical : 2 | 18558 | All ages | Both: 1 | Unspecified:0 | Unspecified:0 | Yes:1 | No:2 | No:2 | No:2 | No:2 | Self reported hearing assessment | Yes:1 | Childhood cognitive development tests | No:2 | Yes:1 | glycosylated haemoglobin, total and high density lipoprotein (HDL) cholesterol, triglycerides, fibrinogen, C-reactive protein, tissue plasminogen activator (t-PA), von Willebrand factor, total immunoglobulin E (IgE) | No:2 | Yes:1 | BP, HR | Antropometric measures, Spirometry, visual acuity | Immortalised cell lines were created and DNA extracted and stored | Birth Cohort | Unknown: 0 | |||||||||||||||||||||||||||||||||||||
23 | 313 | Receptive (aural) vocabulary development in children with permanent bilateral sensorineural hearing impairment | CKIESE-HIMMEL | Professor Dr rer nat Dipl-Psych Christiane Kiese-Himmel, Clinical Psychologist, E-mail: ckiese@med.uni-goettingen.de | 1994 - (unspecified date) | 1994 German Goettinger Hearing Language Register | SNHL - undifferentiated | SNHL - Undifferentiated | Grant from the Annelie-Frohn Stiftung | Prospective: 1 | Clinical : 2 | 33 | Mean age at first testing point 56.2months | Both: 1 | Bilateral:2 | SNHL: 1 | Yes:1 | No:2 | Yes:1 | No:2 | Yes:1 | Yes:1 | Vocabulary assesment | No:2 | No:2 | No:2 | No:2 | If permanent childhoodhearing impairment ismild and/orisdetected early, andif thechild grows up in a monolingual environment, the development of receptive vocabulary within the normal range is possible. | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||
24 | 300 | Executive Dysfunction and Presbycusis in Older Persons With and Without Memory Loss and Dementia | GA. Gates, LE Gibbons, SM McCurry, PK Crane, MP Feeney and EB Larson | George A. Gates, MD, Virginia Merrill Bloedel Hearing Research Center, University of Washington, Box 357923, CHDD Bldg. RM CD176, Seattle, WA 98195-7923 (e-mail: ggates@ u.washington.edu) | 1994 - (unspecified) | Adult Changes in Thought surveillance cohort | SNHL - ARHL | USA | Other disease registries/cohorts | Prospective: 1 | Clinical : 2 | 313 | Men 80 (+/- 5.6), women 79 (+/- 5.2) | Both: 1 | Both:3 | ARHL: 3 | Yes:1 | Yes:1 | Yes:1 | Yes:1 | No:2 | Dichotic Sentence Identification test (DSI), Dichotic Digits test (DDT), MLR, LLR | Yes:1 | Trail Making (parts A and B); Clock Drawing, Stroop Color, and Word test; and subtests from the CASI measuring mental concentration (digits backwards, serial 3s) and category fluency. | No:2 | No:2 | No:2 | No:2 | Amplification of sound may be insufficient, because hearing aids do not resolve deficits in cognition or executive functioning. Our results suggest that elderly patients with substantial central auditory dysfunction should be referred for neurologic evaluation and neuropsychologic assessment. | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||
25 | 352 | African American Cardiovascular Study Cohort | Point of contact: Cheryl Nelson | nelsonc@nhlbi.nih.gov | 2000-2012 | African American Cardiovascular Study Cohort | Jackson (US) | Population cohort | National Institutes of Health | Other: 4 | Cohort | Clinical : 2 | 5301 | 21-94 | Unspecified:0 | Unspecified:0 | Yes:1 | No:2 | No:2 | No:2 | Yes:1 | Audiometry, Tympanometry | No:2 | Yes:1 | blood and urine samples | Yes:1 | BP,HR | Demographic and health information was collected during a series of home interviews and clinical examinations, medication use, cigarette smoking, and history of stroke) | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||
26 | 108 | No Association Between Apolipoprotein E or N-Acetyltransferase 2 Gene Polymorphisms and Age-Related Hearing Loss | Piers Dawes, PhD; Hazel Platt, MSc; Michael Horan, MA, MB ChB, PhD; William Ollier, PhD, FRCPath; Kevin Munro, PhD; Neil Pendleton, MB ChB, MRCP, FRCP; Antony Payton, PhD | Antony Payton, Centre for Integrated Genomic Medical Research, Stopford Building, University of Manchester, Oxford Road, Manchester, M13 9PT, UK. E-mail: tony.payton@manchester.ac.uk | 1997-2002 | age-related hearing loss in a cohort of 265 Caucasian elderly volunteers from Greater Manchester, United Kingdom | SNHL - Genetic | Greater Manchester, UK | SNHL - ARHL | Biotechnology and Biological Sciences Research Council (BB/F022441/1) | Prospective: 1 | Clinical : 2 | 265 | 59-88 | Both: 1 | Caucasian | Bilateral:2 | ARHL: 3 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | Yes:1 | No:2 | No:2 | No:2 | NAT2, APOE | 1998 and 2000 | no evidence that the NAT2 and APOE genes are involved in ARHL using a replication population of 265 elderly volunteers | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||
27 | 114 | Sex-specific predictors of hearing-aid use in older persons: The age, gene/environment susceptibility - Reykjavik study | DE Fisher, C Li, HJ Hoffman, MS Chiu, CL Themann, H Petersen, PV Jonsson, H Jonsson, F Jonasson, JE Sverrisdottir, LJ Launer, G Eiriksdottir, V Gudnason, MF Cotch | diana.fi sher@nih.gov | 2002-2006 | AGES-RS | Hearing aid use | Iceland | Population cohort | Intramural Research Programs of the National Institute of Aging ZIAAG007380) and the National Eye Institute (ZIAEY000401), and the National Institute on Deafness and Other Communication Disorders (IAA Y2-C-1004-02), National Institutes of Health (N01-AG-12100), Bethesda, Maryland, USA; the Icelandic Heart Association, Kopavogur, Iceland; the Icelandic Parliament, Reykjavik, Iceland; the University of Iceland Research Fund, Reykjavik, Iceland; and the Helga Jonsdottir and Sigurlidi Kristjansson Research Fund, Reykjavik, Iceland. | Prospective: 1 | Clinical : 2 | 5,764 | 5172 | 67 years and older | Both: 1 | Both:3 | ARHL: 3 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | Yes:1 | review of a series of cognitive examinations and classified as normal, mild cognitive impairment (MCI), or demented by a consensus panel using the Diagnostic and Statistical Manual of Mental Disorders , Fourth Edition (DSM-IV) guidelines | No:2 | No:2 | No:2 | Yes:1 | Blood pressure | depressive symptomology, BMI, Visual acuity, Physical activity level, Diabetes | Hearing-aid use was comparable in Icelandic men and women with moderate or greater hearing loss. Self-recognition of hearing loss was the factor most predictive of hearing-aid use | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||
28 | 355 | American Community Survey 2012 - 2016 | 2012-2016 | American Community Survey 2012 - 2016 | US | Population cohort | U.S. Census Bureau | Other: 4 | Cohort | Clinical : 2 | 3.5 million households/year | all ages | Unspecified:0 | Unspecified:0 | No:2 | No:2 | No:2 | No:2 | No:2 | Self reported hearing assessment | No:2 | Social ( Education, Marital Status, Relationships, Fertility, Grandparents) Economic ( Income, Employment, Occupation, Commuting to Work) Housing(Occupancy and Structure, Housing Value and Costs, Utilities) Demographic Characteristics ( Sex and Age, Race, Hispanic Origin, Housing Units) | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
29 | 4 | Genome-wide association analysis demonstrates the highly polygenic character of age-related hearing impairment | E. Fransen, S. Bonneux, J. Corneveaux, I. Schrauwen, F. Di Berardino, C. White, J.Ohmen, P. Van de Heyning, U. Ambrosetti, M. Huentelman, G. Van Camp, R. Friedman | guy.vancamp@uantwerpen.be | Unspecified | Antwerp University Hospital | SNHL - ARHL | Belgium | SNHL - ARHL | Belgian Science Policy Office Interuniversity Attraction Poles (BELSPO-IAP) programme through the project IAP P7/43-BeMGI, through R01 grant DC010215, the Seaver Foundation, the Schwartz Foundation, and the State of Arizona. | Prospective: 1 | Basic Science: 1 | 2161 | Unspecified:0 | ARHL: 3 | Yes:1 | Yes:1 | No:2 | No:2 | No:2 | Age related hearing loss | A study of the genetic architecture indicates for the first time that ARHI is highly polygenic in nature, with probably no major genes involved. | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
30 | 305 | Distribution of Hearing Loss Characteristics in a Clinical Population | RH Margolis and GL Saly | Robert H. Margolis, PhD, University of Minnesota, Department of Otolaryngology, MMC283, Minneapolis, MN 55455. E-mail: margo001@umn.edu. | 1988 –1989 | archived records of the University of Minnesota Hospital Audiology Clinic | All - undifferentiated | Minnesota, USA | Healthcare database | Registry: 3 | Clinical : 2 | 16,818 | all ages | Both: 1 | Both:3 | Unspecified:0 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | or lack of a validated classification of audiometric characteristics, it has not been possible to characterize the distributions of hearing loss types in various populations. AMCLASS provides that capability. Although distributions of hearing loss characteristics are likely to differ in various clinical settings, this analysis provides prevalence rates of hearing loss configurations, severities, and sites of lesion from a large clinical database against which analyses of other databases can be compared. | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||
31 | 353 | Atherosclerosis Risk in communities Study (ARIC) | PI: David Couper | David_Couper@unc.edu | 1987 | Atherosclerosis Risk in communities Study (ARIC) | USA (Washington County, Forsyth County, Jackson, Minneapolis) | Population cohort | National Heart, Lung, and Blood Institute of the National Institutes of Health | Other: 4 | Cohort | Clinical : 2 | 15,792 | 45-64 | Unspecified:0 | Unspecified:0 | Yes:1 | No:2 | No:2 | No:2 | No:2 | PTA | No:2 | Yes:1 | Cholesterol HDL Cholesterol Triglycerides Fibrinogen Factor VIIc | medical, social, and demographic data | DNA samples were stored for further multiple analyses | Atherosclerosis | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||
32 | 73 | Risk Factors for Hearing Disorders: Epidemiologic Evidence of Change over Time in the UK | A Davis, S Wodd, Ros Healy, H Webb and S Rowe | Adrian Davis, MRC Institute of Hearing Research, Nottingham, UK NG7 2RD | 1983-1988 | Audio case file from Nottingham, Oxford and Sheffield | All - undifferentiated | United Kingdom | ALL - Undifferentiated | Retrospective: 2 | Clinical : 2 | 200 | Both: 1 | Bilateral:2 | Other:6 | SNHL: 1, MHL:3 | virologic tests | (1) that the NICU graduates should be a major target for neonatal screening using ABR or click evoked otoacoustic emissions methods, (2) that better understanding of the etiologies of the NICU hearing-impaired children should eventually lead to a reduction in complication rates for premature babies and those ill at birth, and (3) that the family history group should be effectively targeted on maternity wards and offered neonatal screening as a priority. Finally, all children with meningitis should have a diagnostic assessment of hearing at a reasonable interval post-discharge. | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
33 | 171 | Characteristics and Progression of Hearing Loss in Children with Down Syndrome | Kathryn L. Kreicher, Forest W. Weir, Shaun A. Nguyen, Ted A. Meyer | Kathryn L. Kreicher. Department of Otolaryngology–Head and Neck Surgery, Medical University of South Carolina 135 Rutledge Ave, MSC550, Charleston, SC 29425. kreicher@musc.edu | 2016 - unspecified | Audiological and Genetic Database (AudGenDB) | SNHL - Genetic | USA | Hearing loss population | The AudGenDB is funded by the National Institutes on Deafness and Other Communication Disorders | Registry: 3 | Clinical : 2 | 1318 | 105 000 | mean age 7.1 | Both: 1 | White, Black or African American, Hispanic, Asian, Other | Both:3 | Glue ear: 1, Cholesteatoma: 2 , Other:6 | Mixed HL , Pure Conductive HL and SNHL | Yes:1 | No:2 | No:2 | Yes:1 | Yes:1 | CT, MRI | Children with Down syndrome who have bilateral, mixed hearing loss or a history of seizures are at risk for more severe hearing loss. SNHL and mixed hearing loss should not be overlooked in patients with CHL. All patients with Down syndrome will benefit from serial audiograms, especially those children with SNHL or mixed hearing loss, which is likely to worsen over time | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||
34 | 83 | Prevelance of 2.2 per mile of significant hearing loss at school age suggests rescreening after NHS | Daniel Holzinger, Annette Weishaupt, Paul Fellinger, Christoph Beitel, Johannes Fellinger | D Holzinger: Hospital St. John of God, Institute for Senses and Language, Seilerst€atte 2, 4021, Linz, Austria. daniel.holzinger@bblinz.at | Spring 2009 - 2011 | Austrian school-age children born between 1997 and 2001 | SNHL - undifferentiated | Austria, School age children living in federal state of Carinthia, Austria | ALL - Undifferentiated | Retrospective: 2 | Clinical : 2 | 61 | 10.5 | 7.5 - 13.6 (born between 1997 - 2001) | Both: 1 | Not stated | Bilateral:2 | SNHL: 1 | Yes:1 | Yes:1 | No:2 | No:2 | No:2 | No:2 | Yes:1 | Kaufmann Assessment Battery for children (54) or the Vineland Screener | No:2 | No:2 | No:2 | No:2 | High prevelence of school-age children with significant hearing loss compared the NHS emphasises the need for ongoing awareness of late-onset hearing loss | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||
35 | 33 | Ten-year outcome of newborn hearing screening in Austria | Viktor Weichbold, Doris Nekahm-Heis, Kunigunde Welzl-Mueller | V. Weichbold Tel.: +43 512 504 25438; fax: +43 512 504 23217. viktor.weichbold@uklibk.ac.at | 1990-2003 | Austrian universal neonatal hearing screening | All - undifferentiated | Austria | ALL - Undifferentiated | Retrospective: 2 | clinical : 2 | 321 | 0-60 months | both: 1 | unspecified:0 | other:6 | Congenital sensorineural hearing loss | No:2 | No:2 | No:2 | yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | The success of neonatal hearing screening programs depends on factors subsequent to the detection of congenital hearing impairment through screening: tightly organized follow-up, good parental compliance, and sound training of all involved health care professionals. | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||
36 | 112 | Does COPD have a clinically relevant impact on hearing loss? A retrospective matched cohort study with selection of patients diagnosed with COPD | Gustav Kamenski, Jana Bendova, Waltraud Fink, Andreas Sönnichsen, Wolfgang Spiegel, Sonja Zehetmayer | Dr Gustav Kamenski; kamenski@aon.at | Not specified | Autrian 194 Adults with COPD | All - undifferentiated | Lower Austria | Other disease registries/cohorts | This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. | Retrospective: 2 | Clinical : 2 | 97 | 35+ | Both: 1 | Not stated | Bilateral:2 | Unspecified: 0 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | spirometry | does not support the hypothesisthat there is an association between COPD andhearing impairment | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||
37 | 267 | Prevalence and risk factors for mild and highfrequency bilateral sensorineural hearing loss at age 11 years old: A UK prospective cohort study | Amanda J. Hall, Elizabeth Midgley, Colin Steer, Rachel Humphriss | Amanda J. Hall, Centre for Hearing and Balance Studies, 8 Woodland Road, Bristol, BS8 1TN, UK amanda.hall@bristol.ac.uk | 1991 - 2002 | Avon Longitudinal Study of Parents And Children (ALSPAC) | SNHL - undifferentiated | Avon, UK | Birth Cohort | The UK Medical Research Council (Grant ref: 74882), the Wellcome Trust (Grant ref: 076467), and the University of Bristol provide core support for ALSPAC. | Prospective: 1 | Clinical : 2 | 5032 | 14 000 | 7, 9, and 11 | Both: 1 | White, non-white | Unspecified:0 | Unspecified:0 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | The prevalence of mild and high-frequency bilateral sensorineural hearing loss in the ALSPAC cohort study at age 11 years old was 0.5%. This is lower than prevalence estimates from population studies in the USA. There is some evidence that admission to hospital in the first two years of life may be associated with mild and high-frequency hearing loss, and that parents of these children are more likely to have suspected a hearing problem at age 3 years. | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||
38 | 31 | Mitochondrial 12S rRNA gene mutations affect RNA secondary structure and lead to variable penetrance in hearing impairment | Ester Ballana, Estela Morales, Raquel Rabionet, Ba`rbara Montserrat, Marina Ventayol, Olga Bravo, Paolo Gasparini, Xavier Estivill | X. Estivill Fax: +34 932240899. E-mail address: xavier.estivill@crg.es | Unspecified | Barcelona 443 families with hearing impairment, | SNHL - Genetic | Spain | SNHL - Genetic/Hereditary | ‘‘Fundacio´ La Marato´ de TV3’’ (993610) and ‘‘Instituto de Salud Carlos III,’’ FIS-ISCIII (G03/203). E.B. is the recipient of a FI fellowship from ‘‘Departament d’Universitats i Societat de la Informacio´ ,’’ Generalitat de Catalunya (2003FI00066) | Other: 4 | case-control | clinical : 2 | 443 families | Unspecified:0 | Other:6 | Non syndromic SNHL | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | Yes:1 | No:2 | 12S rRNA gene, GJB2, GJB6 | hearing loss | The reported data confirm the high prevalence of mutation A1555G in deafness cases and the major role of the 12S rRNA gene in hearing. The two novel changes reported here might have different contributions as deafness-related variants. T1291C fulfills the criteria of a disease-causing change. As in the case of mutation A1555G, the underlying phenotype of T1291C is not homogeneous for all family members, providing evidence for the implication of environmental and/or additional genetic factors | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||
39 | 70 | Is Age-Related Maculopathy Related to Hearing Loss? | R Klein, K J Cruickshanks, B E K Klein, D M Nondahl and T Wiley | kleinr@epi.ophth.wisc.edu | 1993-1995 | Beaver Dam Epidemiology of Hearing Loss Study | SNHL - ARHL | North America | Hearing loss population | Supported by grants EYO6594 (Drs R and B Klein) and AG11099 (Dr Cruickshanks) from the National Institute of Health, Bethesda, Md, and a Senior Scientific Investigator Award, from Research to Prevent Blindness, New York, NY (Dr R Klein) | Prospective: 1 | Clinical : 2 | 3397 | 48-92 | Both: 1 | North America | Both:3 | Unspecified: 0, Unspecified: 0 | Yes:1 | Yes:1 | Yes:1 | Colour fundus photographs | No:2 | Cholesterol | Yes:1 | Systolic and diastolic BP | Bone conduction audiometry, medical and family history, history of noise exposure, cardiovascular history, smoking status, visual acuity | These population-based estimates document the frequent coexistence of signs of ARM and hearing loss. As late ARM is an important cause of loss of vision, and hearing loss is associated with diffuculty in communicating, the high frequencies of sensory comorbidity may affect maintenance of independent functioning as people age. | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||
40 | 137 | Long-term Assessment of Systemic Inflammation and the Cumulative Incidence of Age-related Hearing Impairment in the Epidemiology of Hearing Loss Study | SD Nash, KJ Cruickshanks, W Zhan, MY Tsai, R Klein, R Chappell, FJ Nieto, BEK Klein, CR Schubert, DS Dalton, TS Tweed | snash@wisc.edu | 1993-1995 and evaluation every 5 years | Beaver Dam Epidemiology of Hearing Loss Study | SNHL - ARHL | Beaver Dam, Wisconsin, USA | Hearing loss population | National Institutes on Aging, National Eye Institute, National Institute of Diabetes and Digestive and Kidney Diseases, Research to Prevent Blindness | Prospective: 1 | Clinical : 2 | 4926 | 1.073 | 63.8 | 53.2–88.0 | Both: 1 | Unspecified:0 | ARHL: 3 | Yes:1 | No:2 | No:2 | No:2 | Yes:1 | Bone conduction testing | No:2 | No:2 | Yes:1 | CRP, IL-6, TNF-α | No:2 | No:2 | Blood pressure | Associations between long-term serum C-reactive protein levels and incident hearing impairment were observed in the cohort as a whole, but differed significantly by age group, with statistically significant associations observed in adults less than 60 years, participants moving through the peak risk period for hearing impairment over the course of the study | Yes:1 | CRP | Unknown: 0 | ||||||||||||||||||||||||||||||||||||
41 | 6 | Comparative study of mutation spectrums of MT-RNR1 m.1555A>G, GJB2, and SLC26A4 between familial and sporadic patients with nonsyndromic sensorineural hearing loss in Chinese Han | L. Qian, J. Yubin, H. Bing, Z. Liang, L. Lan, Z. Yali, W. Hongyang, W.Dayong, W Qiuju | wangdy301@126.com | 2003 - 2009 | Beijing 301 familial probands and 703 sporadic patients with NSHL | SNHL - Genetic | China | SNHL - Genetic/Hereditary | National Key Basic Research Program of China (No. 2014CB943001), the National Natural Science Foundation of China, Major Project (No. 81120108009), the Key Medical Technology Research Program of China People’s Liberation Army (No. BWS11J026), and the Nursery Foundation of China People’s Liberation Army (No. 14KMZ04). | Prospective: 1 | Basic Science: 1 | 1004 | 0.4 - 51 | Both: 1 | Chinese Han | Unspecified:0 | Yes:1 | Yes:1 | No:2 | No:2 | Yes:1 | No:2 | MT-RNR1 m.1555A>G, GJB2, and SLC26A4 | non-syndromic sensorineural hearing loss | 2003-2009 | Mutations of GJB2, SLC26A4, and MT- RNR1 m.1555A>G are the most important etiological factors in Chinese Han patients, among which SLC26A4 might be the most frequent. | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||
42 | 37 | Surgical Findings and Long-Term Hearing Results in 3,050 Stapedotomies for Primary Otosclerosis: A Prospective Study with the Otology-Neurotology Database | R Vincent, N M Sperling, J Oates, and M Jindal | Robvinc@aol.com | 1991-2004 | Beziers 3,050 stapedotomies | Primary Otosclerosis | NS | CHL - Otosclerosis | NS | Prospective: 1 | Clinical : 2 | 2525 | 47.3 | 8-91 | Both: 1 | NS | Unspecified:0 | SNHL: 1 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | stapedotomy with vein graft interposition for otosclerotic stapes fixation is a safe and successful treatment with sustained long-term hearing improvement | No:2 | No:2 | Unknown: 0 | The Otology-Neurotology Database (ONDB) (AS Multimedia Inc, Cassagne, France) | ||||||||||||||||||||||||||||||||||||||
43 | 356 | Born in Bradford | PI: John Wright | john.wright@bthft.nhs.uk | 2007- | Born in Bradford | Bradford, West Yorkshire in the United Kingdom | Population cohort | Medical Research Council and Economic and Social Research Council (Populations and Systems Medicine / General Population Science Boards | Other: 4 | Cohort | Clinical : 2 | 12500 pregnant woman-13,500 children | all ages | Unspecified:0 | Unspecified:0 | No:2 | No:2 | No:2 | No:2 | No:2 | Medical records | No:2 | Yes:1 | Rubella status, Urinalysis , FBC, Group Antibody, FBC ,Syphilis,HIV,Hepatitis B ,Electrophoresis,MSU TT,Hep C | Medical & Obstetric History,Social Details, medical examination | Yes:1 | Yes:1 | DNA samples were stored for further multiple analyses | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||
44 | 357 | Breakthrough Generations Study | PI: Anthony Swerdlow | 2004 | Breakthrough Generations Study | ? | Population cohort | Breakthrough Breast Cancer and The Institute of Cancer Research (ICR) | Other: 4 | Cohort | Clinical : 2 | 113000 | Unspecified:0 | Unspecified:0 | No:2 | Yes:1 | Blood samples | Questionnaires (how many children a woman has had, and when her pregnancies happened, whether and when she has reached menopause, and whether she has had breast disease. Questions are also asked, for instance, about work, diet, smoking and drinking) | Yes:1 | DNA samples were stored for further multiple analyses | Breast cancer | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||
45 | 253 | Hearing in 44e45 year olds with m.1555A>G, a genetic mutation predisposing to aminoglycoside-induced deafness: a population based cohort study | S Rahman, R Ecob, H Costello, MG Sweeney, AJ Duncan, K Pearce, D Strachan, A Forge, A Davis, M Bitner-Glindzicz | shamima.rahman@ucl.ac.uk | 1958 (1 week duration) - 2004 (follow up) | British 1958 birth cohort | SNHL - Genetic | UK | Birth Cohort | Sparks, the Children’s Medical Research Charity and by a Summer Studentship from the Royal National Institute for Deaf People (now Action on Hearing Loss). Research at the University College London Institute of Child Health and Great Ormond Street Hospital for Children National Health Service Trust benefits from R&D funding received from the National Health Service Executive. MB-G and SR are supported by Great Ormond Street Hospital Children’s Charity | Prospective: 1 | Basic Science: 1 | 7350 | 19 | 44-45 | Both: 1 | Unspecified:0 | SSNHL: 4 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | hearing in those with m.1555A>G is not significantly different from the general population and appears to be preserved at least until 44e45 years of age. | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||
46 | 335 | British 1970 Cohort Study | Principal Investigator: Alice Sullivan | alice.sullivan@ucl.ac.uk | 1970- | British 1970 Cohort Study | England, Scotland and Wales | Population cohort | Economic and Social Research Council,Medical Research Council, British Heart Foundation. | Other: 4 | Cohort | Clinical : 2 | 17198 | All ages | Both: 1 | Unspecified:0 | Unspecified:0 | Yes:1 | No:2 | No:2 | No:2 | No:2 | Self reported hearing assessment | Yes:1 | Childhood cognitive development tests, British Ability Scales | No:2 | Yes:1 | cholesterol and hba1c, storage for future analyses and DNA extraction | No:2 | Yes:1 | BP, HR | Antropometric measurements | Yes:1 | DNA samples were stored for further multiple analyses | Unknown: 0 | |||||||||||||||||||||||||||||||||||||
47 | 369 | British Birth Cohort 1946(1946BC) | PI: Diana Kuh | mrclha.enquiries@ucl.ac.uk | British Birth Cohort 1946(1946BC) | Population cohort | Other: 4 | Cohort | Clinical : 2 | current estimated sample size: 3116 | Unspecified:0 | Unspecified:0 | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
48 | 341 | British Household Panel Survey | Institute for Social and Economic Research of the University of Essex | iser@essex.ac.uk | 1991- | British Household Panel Survey | UK | Population cohort | Health Education Authority | Other: 4 | Cohort | Clinical : 2 | 8000 | Unspecified:0 | Unspecified:0 | No:2 | No:2 | No:2 | No:2 | No:2 | Self reported hearing assessment | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
49 | 358 | British Regional Heart Study (BRHS) | Study Manager: Lucy Lennon | l.lennon@ucl.ac.uk | 1974- | British Regional Heart Study (BRHS) | England, Scotland and Wales | Population cohort | British Heart Foundation | Other: 4 | Cohort | Clinical : 2 | 7735 | 40 and older | Unspecified:0 | Unspecified:0 | No:2 | No:2 | No:2 | No:2 | No:2 | self reported hearing assessment | Yes:1 | Carotid artery ultrasound Pulse wave velocity Ankle brachial pressure index | Yes:1 | blood/urine samples | Anthropometry Weight, Mid-arm circumference, Physical function, Grip strength Walking test, Chair stand test Dental assessments, Physical activity assessmen Actigraph GT3X physical activity monitor worn for 1 week for objective physical activity measures along with a log diary Hearing, eyesight, sleep patterns, activities of daily living, dental health, memory, depression, local environment, medications, personal circumstances (marital status, accommodation) and diet. Test your memory self-completed questionnaire | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||
50 | 359 | British Women’s Heart and Health Study (BWHHS) | PI: JP Casas Romero | julie.a.taylor@ucl.ac.uk | 1999- | British Women’s Heart and Health Study (BWHHS) | England, Scotland and Wales | Population cohort | The study is currently funded by the British Heart Foundation and has been since 2009. The Department of Health funded the study from when it began until 2012. | Other: 4 | Cohort | Clinical : 2 | 4286 | 60 and older | Unspecified:0 | Unspecified:0 | No:2 | No:2 | No:2 | No:2 | No:2 | self reported hearing assessment, medical records | No:2 | Yes:1 | haematology, biochemistry and storage for future analysis | clinical measurements height, weight, blood pressure, lung function and a resting electrocardiogram, Actigraph Hearing, eyesight, sleep patterns, activities of daily living, dental health, memory, depression, local environment, medications, personal circumstances (marital status, accommodation) and diet. Test your memory self-completed questionnaire | DNA samples were stored for further multiple analyses | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||
51 | 167 | Extensive cardiopulmonary resuscitation of preterm neonates at birth and mortality and developmental outcomes | Nicole Fischer, Amuchou Soraisham, Prakesh S. Shah, Anne Synnes, Yacov Rabi, Nalini Singhal, Joseph Y. Ting, Dianne Creighton, Deborah Deweyb, Marilyn Ballantyne, Abhay Lodha on behalf of the Canadian Neonatal NetworkTM (CNN) and the Canadian Neonatal Follow-up Network (CNFUN) Canadian Neonatal Network (CNN) Site Investigators | N. Fischer Department of Pediatrics & Department of Community Health Sciences, Foothills Medical Centre, Room C211, 29 Street NW, Calgary, Alberta, T2N 2T9, Canada. nfischer@hollandbloorview.ca | 2010 - 2012 | Canadian Neonatal Follow-up Network (CNFUN) | SNHL - undifferentiated | Canada | Other disease registries/cohorts | Although no specific funding has been received for this study, organizational support for the Canadian Neonatal Network was provided by the Maternal-Infant Care Research Centre (MiCare) at Mount Sinai Hospital in Toronto, Ontario, Canada. MiCare and the Canadian Neonatal Follow-Up Network are supported by a Canadian Institutes of Health Research (CIHR) Team Grant (CTP 87518), the Ontario Ministry of Health, and in-kind support from Mount Sinai Hospital. | Retrospective: 2 | clinical : 2 | 2760 | neonates | Both: 1 | Unspecified:0 | Other:6 | Mixed HL and SNHL | Yes:1 | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
52 | 232 | Age-Dependent Cost-Utility of Pediatric Cochlear Implantation | YR Semenov, ST Yeh, M Seshamani, NY Wang, EA Tobey, LS Eisenberg, AL Quittner, KD Frick, JK Niparko, the CDaCI Investigative Team | jnipark@jhmi.edu | November 2002 to December 2011 | CDaCI - Childhood Development after Cochlear Implantation (6 CI centres Johns Hopkins) | SNHL - undifferentiated | USA | SNHL - Undifferentiated | National Institute on Deafness and Other Communication Disorders, the CityBridge Foundation, and the Sidgmore Family Foundation | Prospective: 1 | Clinical : 2 | 175 | Both: 1 | Both:3 | SNHL: 1 | Yes:1 | No:2 | No:2 | No:2 | No:2 | Health Utility Index Mark HUI2 and HUI3 surveys | Yes:1 | Bayley Psychomotor Development Index & Leiter-R Brief IQ | No:2 | No:2 | No:2 | No:2 | Early (<18 months) intervention with CI was associated with greater and longer quality of-life improvements, similar direct costs of implantation, and economically valuable improved classroom placement, without a greater incidence of medical and surgical complications when compared to CI at older ages | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||
53 | 322 | Childhood Development after Cochlear Implantation (CDaCI) study: Design and baseline characteristics | NE Fink, NY Wang, J Visaya, JK Niparko, A Quittner, LS Eisenberg, EA Tobey | nfink@jhsph.edu | Unspecified dates (two-year period) | CDaCI - Childhood Development after Cochlear Implantation (6 CI centres Johns Hopkins) | SNHL - undifferentiated | USA | SNHL - Undifferentiated | NIDCD | Prospective: 1 | Clinical : 2 | 188 | 425 | 2.2 | 1-7 | Both: 1 | Both:3 | SNHL: 1 | No:2 | No:2 | No:2 | No:2 | No:2 | No details | Yes:1 | Bayley Scales of Infant Development Mental Scale or Motor Scale (BSID II) and Leiter International Performance Scale-Revised | No:2 | No:2 | No:2 | No:2 | Reynell Development Language Scales (RDLS) | This longitudinal cohort study addresses questions related to high variability in language outcomes. Identifying sources of that variance requires research designs that: characterise potential predictors with accuracy, use samples that adequately power a study, and employ controls and approaches to analysis that limit bias and error. The CDaCI study was designed to generate a more complete picture of the interactive processes of language learning after implantation | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||
54 | 71 | Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection | K B Fowler, F P McCollister, A J Dale, S Boppana, W J Britt and R F Pass | Karen B. Fowler, DrPH, Department of Pediatrics, University of Alabama at Birmingham, 1600 7th Ave. South, Suite 752, Birmingham, AL 35233. | 1980-1995 | Chiildren born between 1980-1995 who were identified by newborn screening for congenital CMV infection at two hospitals in Birmingham, Ala | SNHL - Infectious | North America | Other disease registries/cohorts | Supported in part by a research grant (5 P01 HD 10699) from the National Institute of Child Health and Human Development, a re- search grant (5 R01 DC 02139) from the National Institute on Deafness and Other Communication Disorders, and a research grant (5 M01 RR 00032) from the General Clinical Research Center, Na- tional Institutes of Health, the Deafness Research Foundation, and the Civitan International Research Center. | Prospective: 1 | Clinical : 2 | 307 | 424 | Both: 1 | Both:3 | SNHL: 1 | Yes:1 | Yes:1 | Yes:1 | Yes:1 | CMV Serologic tests, otoscopy | Otoscopy | Asymptomatic congenital CMV infection is likely a leading cause of SNHL in young children. The continued deterioration of hearing and delayed onset of SNHL in these children emphasizes the need for continued monitoring of their hearing status | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||||
55 | 30 | Hearing Genes and Cisplatin Deafness: A Pilot Study | Christine Knoll, Richard J. H. Smith, Carol Shores, Julie Blatt | Julie Blatt, University of North Carolina School of Medicine, CB 7220 Chapel Hill, NC, 27599-7220, U.S.A. jblat@med.unc.edu | Unspecified | Childhood Cancer Survivor Study database | SNHL - Genetic | United States | Other disease registries/cohorts | Retrospective: 2 | Clinical : 2 | 11 | 1250 | younger than | both: 1 | Unspecified:0 | Other:6 | Ototoxicity Drug induced hearing loss | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | Yes:1 | No:2 | GJB2 , SLC26A4, mtDNA genes | Childhood Cancers (Osteosarcoma, Soft tissue sarcoma, CNS tumor | 2003 | It is unlikely that mutations in GJB2 or SLC26A4 or the 3 mtDNA mutations A1555G, A3243G, or A7445G contribute to cisplatin ototoxicity. Nonetheless, the current study should be considered only a pilot and continued study of this population should remain a priority. | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||
56 | 350 | China Ageing REespiratory infections Study (CARES) | Cowling BJ, Xu C, Tang F, Zhang J, Shen J, Havers F, Wendladt R, Leung NH, Greene C, Iuliano A, Shifflett P, Song Y, Zhang R, Kim L, Chen Y, Chu DK Zhu H, Shu Y, Yu H, Thompson MG; CARES investigators | Correspondence to Dr Benjamin J Cowling: kh.ukh@gnilwocb | 2015-2016 | China Ageing REespiratory infections Study (CARES) | Eastern China | Population cohort | Influenza Division of the US Centers for Disease Control and Prevention | Other: 4 | Cohort | Clinical : 2 | 1532 | 60-89 | Unspecified:0 | Unspecified:0 | No:2 | No:2 | No:2 | No:2 | No:2 | Self reported hearing impairment (Groningen Frailty Index) | No:2 | Yes:1 | Blood samples,mid-turbinate nasal and oropharyngeal swabs | baseline data on demographics, general health, chronic diseases, functional status and cognitive function through face-to-face interviews using a standardised questionnaire | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||||
57 | 296 | Mitochondrial 12S rRNA variants in 1642 Han Chinese pediatric subjects with aminoglycoside-induced and nonsyndromic hearing loss | J Lu, Z Li, A Yang, R Li, J Zeng, Q Cai, G Peng, W Tang, B Chen, J Chen, Z Liao, L Yang, Y Li, J You, Y Ding, H Yu, J Wang, D Sun, J Zhao, L Xue and M-X Guan | min-xin.guan@cchmc.org | Unspecified dates | Chinese 1642 unrelated hearing-impaired subjects | SNHL - Genetic | China | SNHL - nonsyndromic - undifferentiated | This work was supported by Public Health Service grants RO1DC05230 and RO1DC07696 from the National Institute on Deafness and Other Communication Disorders, and grants from National Basic Research Priorities Program of China 2004CCA02200, Ministry of Public Heath of Zhejiang Province 2006A100, Ministry of Science and Technology of Zhejiang Province 2007G50G2090026 and Zhejiang Provincial Program for the Cultivation of High level Innovative Health talents to M.X.G. and Ministry of Science and Technology of Wenzhou City Y20060089 to Z.L. and Natural Science Foundation of Zhejiang Province Y207307 to Y.Z. | Prospective: 1 | 3284 | Paediatric | Both: 1 | Han Chinese | Unspecified:0 | Other:6 | Deafness, aminoglycoside-induced and nonsyndromic hearing impairmen | Yes:1 | Yes:1 | Yes:1 | No:2 | No:2 | Yes:1 | No:2 | 12S rRNA gene, GJB2, TRMU | Mutational analysis of 12S rRNA gene in these subjects identified 68 (54 known and 14 novel) variants. The frequencies of known 1555A>G and 1494C>T mutations were 3.96% and 0.18%, respectively, in this cohort with nonsyndromic and aminoglycoside-induced hearing loss. | Yes:1 | 68 (54 known and 14 novel) variants | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||
58 | 84 | The European GWAS-identified risk SNP rs457717 within IQGAP2 is not associated with age-related hearing impairment in Han male Chinese population | Huajie Luo, Hao Wu, Hailian Shen, Haifeng Chen, Tao Yang, Zhiwu Huang, Xiaojie Jin, Xiuhong Pang, Lei Li, Xianting Hu, Xuemei Jiang, Zhuping Fan, Jiping LI. | Jiping LI drlijiping@163.com Huajie Luo luohuajie2000@qq.com | Participants recruited between 07/2011 - 07/2014 | Chinese Han 2420 patients with ARHI | SNHL - Genetic | Xinhua and RenJi Hospitals, Shanghai | SNHL - ARHL | Grants from Medical Engineering (Technology) Cross Research Fund, Shanghai Jiao Tong University (No. YG2014MS47), and grants from the Medical Research Fund of Shanghai Municipal Health and Family Planning Commission (No. 201440295). | Retrospective:2 | Basic Science: 1 | 2420 | 50-100 | Male: 3 | Southern Chinese HAN population (Asian) | Unspecified:0 | ARHL: 3 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | Yes:1 | No:2 | No:2 | No:2 | IQGAP2 | IQGAP2 and ARHI in an Asian ethnic group, IQGAP2 risk SNP locus (rs457717: A/G) in intron 13 identified by a European GWAS was not associated with ARHI in Han male Chinese individuals. | No:2 | Unknown: 0 | QUANTO software version 1.2 4. All calculations were performed using the statistical software package 19.0.0 (IBM SPSS Statistics, Inc., Chicago, IL). | ||||||||||||||||||||||||||||||||||
59 | 229 | Cochlear implantation in patients deafened by ototoxic drugs | J Nichani, IA Bruce, D Mawman, S Khwaja, R Ramsden, K Green | jaya.nichani@cmft.nhs.uk | 1997 to 2011 | CI program - Manchester Auditory Implant Centre database | SNHL - Iatrogenic | Manchester, UK | SNHL - Undifferentiated | Prospective: 1 | Clinical : 2 | 14 | Both: 1 | Unspecified:0 | Other:6 | No:2 | No:2 | No:2 | No:2 | No:2 | Bamford–Kowal–Bench (BKB) word test | No:2 | No:2 | No:2 | No:2 | No:2 | Patients with profound hearing loss secondary to ototoxic agents can be rehabilitated successfully with CI. The outcomes may be variable and may be dependent on the underlying pathology for which the ototoxic agents were prescribed | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||
60 | 286 | Prevalence of Connexin 26 (GJB2) and Pendred (SLC26A4) Mutations in a Population of Adult ochlear Implant Candidates | JB Hochman, TL Stockley. D Shipp, VYW Lin, JM Chen and JM Nedzelski | jordanhochman@ hotmail.com | November 2007 - April 2009 | CI program (Sunnybrook Health Sciences Centre-Quaternary Healthcare Facility) | SNHL - Genetic | Canada | SNHL - Undifferentiated | Prospective: 1 | Bilateral:2 | Other:6 | severe sensorineural hearing loss | Yes:1 | Yes:1 | Yes:1 | computer tomography of the petrous bone, otomicroscopy | Yes:1 | electronystagmography | No:2 | No:2 | Yes:1 | exon sequencing | GJB2, GJB6, SLC26A4 | The prevalence of GJB2- and SLC26A4-related hearing impairment in an adult population with early-onset severe sensorineural hearing loss is significant, suggesting the need for routine assessment for genetic etiologies in this group. | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||||
61 | 268 | A Descriptive Analysis of Language and Speech Skills in 4- to 5-Yr-Old Children With Hearing Loss | Elizabeth M. Fitzpatrick, Leah Crawford, Andy Ni, Andre´e Durieux-Smith | Elizabeth M. Fitzpatrick, Faculty of Health Sciences, Audiologie-Speech-Language Pathology, 451 Smyth Road (3071), Ottawa, Ontario K1H 8M5, Canada elizabeth.fitzpatrick@uottawa.ca. | 1999 to 2004 | CI programmes (x3) in Ontario, Canada | SNHL - undifferentiated | Ottawa and Toronto, Canada | SNHL - Undifferentiated | Canadian Language and Literacy Research Network and the Masonic Foundation of Ontario. E. M. Fitzpatrick received funding through a Canadian Institutes of Health Research New Investigator Award. | Other: 4 | Observational | Clinical : 2 | 88 | 4-5 | Both: 1 | Unspecified:0 | Other:6 | Children with SNHL who received a HA or a CI | Peabody Picture Vocabulary Test, Third Edition (PPVT-III), the Preschool Language Scale, Fourth Edition (PLS-4), and the Goldman-Fristoe Test of Articulation, Second Edition (GFTA-2), | No:2 | No:2 | No:2 | No:2 | The Child Development Inventory (CDI) | Results indicated that overall, children with all degrees of hearing loss who were fit with hearing technology and who received auditory-based rehabilitation services during the preschool years demonstrated the potential to develop spoken language communication skills. As a group, children with CIs and children with HAs did not differ significantly on language abilities although there were differences in articulation skills. Their performance at age 4 to 5 yrs was delayed compared with a group of hearing peers. | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||
62 | 270 | Etiology profile of the patients implanted in the cochlear implant program | Clara Maria Dias Ferreira Calháu, Luiz Rodolpho Penna Lima Júnior, Ana Maria da Costa dos Santos Reis, Ana Karla Bigois Capistrano, Danielle do Vale Silva Penna Lima, Ana Carolina Dias Ferreira Calháu, Fábio de Alencar Rodrigues Júnior | Rua Dr. José Gonçalves 1963 - Lagoa Nova 59056-570 | August 2000 - May 2008 | CI progrram- Brazil | SNHL - undifferentiated | Brazil | SNHL - Undifferentiated | Retrospective: 2 | Clinical : 2 | 200 | 1-73 | Both: 1 | Unspecified:0 | Unspecified:0 | unknown etiology continues prevailing, which points to the need of carrying out genetic studies, in cases of congenital sensorineural hearing loss without an apparent cause, with the goal of reaching a real etiologic profile. Rubella was the second most commonly found cause, and for this etiology there already are preventive measures, similarly to what we have for meningitis. Even then, the incidences of these diseases are still high | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
63 | 283 | Functional Null Mutations of MSRB3 Encoding Methionine Sulfoxide Reductase Are Associated with Human Deafness DFNB74 | ZM Ahmed, R Yousaf, BC Lee, SN Khan, S Lee, K Lee, T Husnain, AU Rehman, S Bonneux, M Ansar, W Ahmad, SM Leal, VN Gladyshev, IA Belyantseva, GV Camp, S Riazuddin, TB Friedman and S Riazuddin | saima.riazuddin@cchmc.org | Unspecified dates | Cincinnati 5 consanguinous families with NSHL | SNHL - Genetic | Pakistan | SNHL - Genetic/Hereditary | This work was supported by Cincinnati Children’s Hospital Research Foundation (CCHMC) intramural research funds to SR and ZA, the National Institute on Deafness and Other Communication Disorders, National Institutes of Health (NIDCD/NIH) research grant R00-DC009287-03, a Career Development Award from Research to Prevent Blindness (to Z.A.), and National Institute on Aging, NIH grant AG021518 (to V.N.G.) . Work in Pakistan was supported by the Higher Education Commission to S.R. (Lahore); funding from World Health Organization Regional Office for the Eastern Mediterranean (EMRO) and COMSTECH (Organization of the Islamic Conference [OIC] Standing Committee on Scientific and Technological Cooperation) and from the Ministry of Science and Technology (MoST) to S.R. (Lahore); the International Center for Genetic Engineering and Biotechnology, Trieste, Italy under project CRP/PAK08-01 contract no. 08/009 to S.R. (Islamabad). Part of the work was funded by the Higher Education Commission (HEC), Government of Pakistan, and the NIH National Institute of Deafness and other Communication Disorders grant DC03594 to S.M.L. Genotyping services were partially provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the NIH to The Johns Hopkins University, contract number N01-HG-65403. Work at NIDCD/ NIH was supported by intramural funds DC00039-14 to T.B.F | Prospective: 1 | 1040 | 53-67 | Both: 1 | Unspecified:0 | Unspecified:0 | Yes:1 | tandem-gait and Romberg testing, fundoscopy | Yes:1 | Genome Wide Linkage Analysis | DFNB74, MSRB3 | In summary, an in vitro assay revealed that p.Cys89Gly completely abolished MSRB3 enzymatic activity and that p.Arg19X is a null allele for MSRB3 mitochondrial isoforms, indicating that DFNB74 deafness might be a mitochondrial disease limited to the inner ear. | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
64 | 41 | Audiometric, clinical and educational outcomes in a pediatric symptomatic congenital cytomegalovirus (CMV) population with sensorineural hearing loss | C Madden, S Wiley, M Schleiss, C Benton, J Meinzen-Derr, J Greinwald, D Choo | daniel.choo@cchmc.org | Unspecified | Cincinnatii Paediatric hearing impaired database | SNHL - Infectious | North America | ALL - Undifferentiated | Retrospective: 2 | Clinical : 2 | 21 | 1500 | neonates | Both: 1 | Unspecified:0 | SNHL: 1 | Yes:1 | Yes:1 | Yes:1 | Non-contrast cranial computed tomography and magnetic resonance imaging (MRI) scans | No:2 | No:2 | No:2 | Statistical associations between clinical findings such as hepatic dysfunction, CP and hearing level were identified | No:2 | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||
65 | 342 | CLOSER The Cohort and Longitudinal Studies Enhancement Resources | CLOSER The Cohort and Longitudinal Studies Enhancement Resources | Population cohort | Other: 4 | Cohort | Clinical : 2 | Unspecified:0 | Unspecified:0 | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
66 | 166 | Racial and Ethnic Differences in the Prevalence of Congenital Cytomegalovirus Infection | Karen B. Fowler, Shannon A. Ross, Masako Shimamura, Amina Ahmed, April L. Palmer, Marian G. Michaels, David I. Bernstein, Pablo J. Sánchez | Karen B. Fowler, DrPH, Department of Pediatrics, University of Alabama at Birmingham, 1600 7th Avenue South CHB 304, Birmingham, AL 35233. kfowler@uab.edu | Unspecified | CMV and Hearing Multicenter Screening (CHIMES) Study | SNHL - Infectious | US | Other disease registries/cohorts | Supported by the National Institute on Deafness. Other Communication Disorders (NIDCD) provided grant support for the CHIMES Study (N01 DC50008, HHS-N- 263-2012-00010-C) | Registry: 3 | Clinical : 2 | 100.332 | infants | Both: 1 | American Indian, Asian, Black, White, Hispanic, White, non-Hispanic, Multiracial | Unspecified:0 | SNHL: 1 | No:2 | Yes:1 | CMV, Bilirubin | No significant differences in symptomatic cCMV and sensorineural hearing loss were observed between the race/ethnic groups. | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
67 | 360 | Cognitive Function and Ageing Studies I (CFAS I) | CI:Carol Brayne | cb105@medschl.cam.ac.uk | 1989- | Cognitive Function and Ageing Studies I (CFAS I) | UK | Population cohort | Medical Research Council | Other: 4 | Cohort | Clinical : 2 | 18000 | 65 and older | Unspecified:0 | Unspecified:0 | Yes:1 | No:2 | No:2 | No:2 | No:2 | Hearing test, self reported hearing impairment | Yes:1 | No:2 | Yes:1 | Blood, saliva samples | Orientation, demographics, cognitive functions,medical history, | DNA samples were stored for further multiple analyses | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||
68 | 361 | Cognitive Function and Ageing Studies II (CFAS II) | CI:Carol Brayne | cb105@medschl.cam.ac.uk | 2008 | Cognitive Function and Ageing Studies II (CFAS II) | Cambridgeshire, Newcastle and Nottingham | Population cohort | UK Medical Research Council, Alzheimer’s Society UK and utilised resources of the UK National Institute of Health Research collaboration for leadership in applied health research and care for Cambridgeshire and Peterborough and the Cambridge Biomedical Research Centre infrastructures, Nottingham city and Nottinghamshire county NHS primary care trusts, and UK NIHR biomedical research centre for ageing and age-related disease award to Newcastle Upon Tyne hospital foundation trust | Other: 4 | Cohort | Clinical : 2 | >5000 | 65 and over | Unspecified:0 | Unspecified:0 | Yes:1 | No:2 | No:2 | No:2 | No:2 | Hearing test | No:2 | Yes:1 | blood, saliva, postmortem brain donations | DNA samples were stored for further multiple analyses | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||||
69 | 22 | Prevalence of auditory neuropathy/synaptopathy in a population of children with profound hearing loss | Astrid Foerst , Dirk Beutner, Ruth Lang-Roth, Karl-Bernd Huttenbrink, Hasso von Wedel, Martin Walger | Astrid Foerst : Tel.: +49 221 478 4769/3711; fax: +49 221 478 3581 astrid.foerst@uni-koeln.de (A. Foerst). | 1997 -2004 | Cologne 5190 children, with profound hearing loss or risk or risk of HL | SNHL- ANSD | Germany | SNHL - ANSD | scholarship of the ‘‘Novartis-Stiftung fu¨r therapeutische Forschung’’ to Dirk Beutner | Retrospective: 2 | Clinical : 2 | 5190 | 1-15 | Both: 1 | Unspecified:0 | Unspecified: 0 | Yes:1 | Yes:1 | Yes:1 | No:2 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | More research aiming to investigate infectious backgrounds of auditory dysfunction is needed. Results of the present study indicate - but do not prove -that two common epidemic diseases, influenza and possibly pertussis, are hitherto unrecognized pre or early postnatal risk factors for mild hearing loss in young adulthood. | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||
70 | 24 | The incidence of hearing impairment after successful treatment of neuroblastoma | T. Simon , B. Hero , W. Dupuis- , B. Selle , F. Berthold | Thorsten Simon Zentrum fur Kindreonkologie und Hämatologie Joseph-Stelzmann-Strabe 9. 50924 Köln Thorsten.simon@medizin.uni-koeln.de | Unspecified | Cooperative German Neuroblastoma Trials NB90 and NB97 | SNHL - Iatrogenic | Germany | Other disease registries/cohorts | Retrospective: 2 | Clinical : 2 | 1170 | children | Both: 1 | Unspecified:0 | Unspecified: 0 | Unspecified hearing tests | One fourth of of high risk Neuroblastoma survivors suffer from treatment induced hearing impairment. The substitution of cisplatin with carboplatin was not associated with increased rate of tumor recurrences. (However they were not able to detect the ototoxicity of Carboplatin as it was administered after the hearing loss was documented. | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
71 | 68 | Prevalence of hereditary hearing impairment in adults | Y Sakihara, B Christensen and A Parving | bbhaudap@pip.dknet.dk | 1987-1991 | Danish Birth Cohort | SNHL - Genetic | Denmark | Birth Cohort | Retrospective: 2 | Clinical : 2 | 1265 | 27692 | 70 | 22-98 | Both: 1 | Both:3 | SNHL: 1 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | the established database may be of importance in the aggregation of very rare diseases, and for providing the inspiration for future prospective population studies, resulting in knowledge on the epidemiology of hereditary hearing impairment in adults. | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||
72 | 139 | Atherogenic Risk Factors and Hearing Thresholds | TW Frederiksen, CH Ramlau-Hansen, ZA Stokholm, MB Grynderup, AM Hansen, SP Lund, JM Vestergaard, J Kristiansen, JP Bonde, HA Kolstad | thofre@rm.dk | 2009-2010 | Danish workers survey | SNHL - NIHL | Aarhus, Denmark | Occupational | Danish Work Environment Research Fund | Prospective: 1 | Clinical : 2 | 576 | 665 | 39.8-53.4 | Both: 1 | Unspecified:0 | Unspecified:0 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | Yes:1 | LDL, HDL, TG | No:2 | Yes:1 | Blood pressure | Atherogenic risk factors seemed associated with increased low-frequency hearing thresholds, but only at a borderline level of statistical significance. Associations were generally strongest with hearing levels of the worst hearing ear. We found no statistically significant associations between atherogenic risk factors and high-frequency hearing thresholds. | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||
73 | 233 | Sensorineural Hearing Loss Incidence Among U.S. Military Aviators Between 1997 and 2011 | CA Orsello, JE Moore, C Reese | orselloc@yahoo.com | 1997 and 2011 | Defense Medical Epidemiological Database DMED | SNHL - NIHL | USA | Occupational | Retrospective: 2 | Clinical : 2 | 467064 | 20 to above 40 | Both: 1 | Both:3 | SNHL: 1 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | The average annual incidence rate of SNHL between 1997-2011 was higher for fi xed than for rotary-wing aviators, and higher for U.S. Army and Air Force than Navy and Marine aviators. | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||
74 | 165 | Whole-genome sequencing reveals new insights into age-related hearing loss: cumulative effects, pleiotropy and the role of selection | Dragana Vuckovic, Massimo Mezzavilla, Massimiliano Cocca, Anna Morgan, Marco Brumat, Eulalia Catamo, Maria Pina Concas, Ginevra Biino, Annamaria Franzè, Umberto Ambrosetti, Mario Pirastu, Paolo Gasparini, Giorgia Girotto | dragana.vuckovic@burlo.trieste.it | Unspecified | Discovery Cohort | SNHL - Genetic | Italy | SNHL - ARHL | RBSI14AG8P-SIR2014 to GG. | Prospective: 1 | Basic Science: 1 | 212 | >50 | Both: 1 | Unspecified:0 | ARHL: 3 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | Yes:1 | No:2 | No:2 | No:2 | In conclusion, we show that this multistep strategy (WGS, selection, expression, pathway analysis and targeted re-sequencing) can provide major insights into the molecular characterization of complex diseases such as ARHL. | Yes:1 | additional functional studies of CSMD1 and PTPRD genes/variants | Unknown: 0 | |||||||||||||||||||||||||||||||||||||
75 | 362 | Dunedin Multidisciplinary Health and Develoment Study | Director: Richie Poulton | richie.poulton@otago.ac.nz | 1972- | Dunedin Multidisciplinary Health and Develoment Study | Dunedin, New Zealand | Population cohort | New Zealand Ministry of Business, Innovation and Employment in 2015.Major funders include the Health Research Council of New Zealand, US National Institutes of Health (various branches) and the UK Medical Research Council | Other: 4 | Cohort | Clinical : 2 | 1037 | All ages | Unspecified:0 | Unspecified:0 | Yes:1 | No:2 | No:2 | No:2 | Yes:1 | Audiometry, tympanometry, self reported survey | No:2 | Perinatal, demographic and anthropometric information | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||||||
76 | 32 | Outcome at 2 years for very low birthweight infants in a geographical population: Risk factors, cost, and impact of congenital anomalies | A. Salt, A. D’Amore, J. Ahluwalia, A. Seward, S. Kaptoge, S. Halliday, J. Dorling | J. Dorling Tel.: +44 116 252 5879; fax: +44 116 252 3282. jsd10@le.ac.uk | 1993—1997 | East Anglian Very Low Birthweight Project | SNHL - undifferentiated | East Anglia | Other disease registries/cohorts | Funding was initially received from regional audit funds, funding from regional research and development and from the Anglia Clinical Audit and Effectiveness Team in Cambridge | prospective: 1 | clinical : 2 | 947 | 2 | Both: 1 | unspecified:0 | Unspecified:0 | Unspecified hearing tests | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||||||
77 | 363 | East London Genes and Health | CI: David van Heel | d.vanheel@qmul.ac.uk | 2015- | East London Genes and Health | East London | Population cohort | Wellcome Trust | Other: 4 | Cohort | Clinical : 2 | target: 100000 | All ages | Unspecified:0 | Unspecified:0 | No:2 | No:2 | No:2 | No:2 | No:2 | Medical records | No:2 | Yes:1 | Blood, saliva | Medical records, questionnaires: Anthropometric: Height, Weight, Blood pressure Physical: Cardiovascular, Respiratory, Musculoskeletal, Hearing and vision, Reproductive Psychological: Mental health, Cognitive function Lifestyle: Smoking, Physical activity, Dietary habits, Alcohol Socio-economic: Ethnic group | Yes:1 | No:2 | No:2 | 2018, 2019, 2020 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||
78 | 185 | Association of Cognition and Age-Related Hearing Impairment in the English Longitudinal Study of Ageing | J Ray, G Popli and G Fell | g.popli@shef.ac.uk | 2002 - unspecified, objective hearing data 2014 - 15 | English Longitudinal Study of Ageing (ELSA) | SNHL - ARHL | United Kingdom | Population cohort | Retrospective: 2 | cross-sectional analysis | Clinical : 2 | 7385 | 9666 | >50 | Both: 1 | Unspecified:0 | ARHL: 3 | No:2 | No:2 | No:2 | No:2 | No:2 | HearCheck screener device (Siemans) | Yes:1 | simple tests of memory and executive function (outlined in methods) | No:2 | No:2 | No:2 | No:2 | Although hearing loss and cognition are linked, untreated hearing loss drives the association. Social isolation is a mediating factor only for those who have untreated hearing loss. Authors found that cognitive decline associated with ARHI is probably preventable by early rehabilitation and increased opportunistic screening for the elderly | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||
79 | 25 | Epidemiology of Permanent Childhood Hearing Impairment in Estonia, 1985-1990 | Kai Uus & Adrian C. Davis | 1985-1990 | Estonian birth cohort 1985-90 | SNHL - undifferentiated | Estonia | Birth Cohort | Estonian Science Foundation Grant No:2376 | Retrospective: 2 | Clinical : 2 | 248 | 8-13 | Both: 1 | Unspecified:0 | Unspecified: 0 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||
80 | 364 | European Prospective Investigation of Cancer Norfolk (EPIC – Norfolk) | PI: Kay-Tee Khaw | epic@srl.cam.ac.uk | 1993- | European Prospective Investigation of Cancer Norfolk (EPIC – Norfolk) | Norfolk (UK) | Population cohort | MRC Programme Gran | Other: 4 | Cohort | Clinical : 2 | 30000 | 40 and older | Unspecified:0 | Unspecified:0 | No:2 | No:2 | No:2 | No:2 | No:2 | self reported hearing assessment | Yes:1 | ultrasound measurement of heel bone | Yes:1 | Blood and urine samples | Demographics,height, weight, waist, hip and chest measurements,blood pressure and lung capacity, density and impedance assessment of total body fat cognition, visual function and physical performance, grip strength, balance test, gait speed and chair stand, body composition, including lean muscle mass by DEXA, and physical activity and sedentary behaviour, by accelerometry (Actigraph),diet | Yes:1 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||
81 | 15 | Functional Variants in NOS1 and NOS2A Are Not Associated with Progressive Hearing Loss in Me ́nie`re’s Disease in a European Caucasian Population | I.Gazquez,1,2 Jose A. Lopez-Escamez,1,3 Antonia Moreno,2 Colleen A. Campbell,4 Nicole C. Meyer,4 John P. Carey,5 Lloyd B. Minor,5 Bruce J. Gantz,4 Marlan R. Hansen,4 Charles C. Della Santina,5 Ismael Aran,6 Andres Soto-Varela,7 Sofia Santos,7 Angel Batuecas,8 Herminio Perez-Garrigues,9 Alicia Lopez-Nevot,10 Richard J.H. Smith,4 and Miguel A. Lopez-Nevot2 | antonio.lopezescamez@genyo.es | 2005 - 2010 | European two independent MD sets(273 patients in total) and 550 controls. | Meniere's Disease | Spain | Other disease registries/cohorts | IS PI10/0920 Research Project from ISCIII. J.A.L.-E. was partially supported by ISCIII research grant INT09/229. The 3130 XL Genetics Analyzer was funded by grant IF06/37291 from Ministry of Science. This work was partially supported by the University of Iowa, Department of Otolaryngology and the Research Fund of the American Otological Society (to R.J.H.S.) | Prospective: 1 | Basic Science: 1 | 823 | 273 | Both: 1 | Unspecified:0 | SNHL: 1 | Yes:1 | Caloric testing | No:2 | No:2 | Yes:1 | No:2 | NOS1, NOS2A | Meniere's Disease | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||||
82 | 36 | Hearing loss in Fabry disease: data from the Fabry Outcome Survey | S. Hegemann, D. Hajioff, G. Conti, M. Beck, G. Sunder-Plassmann, U. Widmer, A. Mehta, and A. Keilmann | Dr D. Hajioff, Department of Otolaryngology, Southmead Hospital, Bristol, BS10 5NB, UK. Tel.: +44 117950 5050; fax: +44 117959 5850; ejci@hajioff.fmail.co.uk | 2004 | Fabry Outcome Survey | SNHL - Genetic | Germany, UK, Czech Republic, Switzerland, Italy, Spain, France, Belgium, Norway, Sweden, Austria | Other disease registries/cohorts | Shire Human Genetic Therapies, Cambridge, MA, USA | Registry: 3 | Clinical : 2 | 638 | 14-66 | Both: 1 | unspecified:0 | Unspecified:0 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | In general, hearing in Fabry patients resembles the age-related hearing loss in a normal population but starts earlier and progresses faster. Male patients had more severe hearing loss than female patients | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||
83 | 222 | Addition of host genetic variants in a prediction rule for post meningitis hearing loss in childhood: a model updating study | MS Sanders, RCJ de Jonge, CB Terwee, MW Heymans, I Koomen, S Ouburg, L Spanjaard, SA Morré, AM van Furth | r.c.j.dejonge@erasmusmc.nl | 1986-2001 | Files of the Netherlands Reference Laboratory for BM (NRLBM) | SNHL - Genetic | the Netherlands | SNHL - Infectious | Prospective: 1 | Clinical : 2 | 669 | 1605 | 2.6 | 0 – 9 | Both: 1 | Dutch-Caucasian | Unspecified:0 | Other:6 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | Yes:1 | No:2 | TLR2, TLR4, TLR9, NOD1, NOD2, CASP1, TRAIL-692T | Bacterial meningitis | addition of genetic risk factors did not significantly improve the clinical prediction model for post-meningitis hearing loss | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||
84 | 227 | Independent Validation of an Existing Model Enables Prediction of Hearing Loss after Childhood Bacterial Meningitis | RCJ de Jonge, MS Sanders, CB Terwee, MW Heymans, RJBJ Gemke, I Koomen, L Spanjaard, AM van Furth | r.c.j.dejonge@erasmusmc.nl | 1986-2001 | Files of the Netherlands Reference Laboratory for BM (NRLBM) | SNHL - Infectious | the Netherlands | SNHL - Infectious | Prospective: 1 | Clinical : 2 | 358 | 1605 | Unspecified:0 | Other:6 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | This prediction model for identifying children at risk for hearing loss after bacterial meningitis might be used as a screening tool and can help to identify those children that need special attention and a long follow-up period or more frequent auditory testing | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||
85 | 26 | Prevalance of hearing loss at the age of 15 in a birth cohort of 12000 children from northern Finland | Martti Sprri, Paula Rantakallio | 1966 | Finland Birth Cohort from 1966 | SNHL - undifferentiated | Finland, Finland, Finland | Birth Cohort | Other: 4 | Cross-sectional | Clinical : 2 | 425 | 11780 | 14 | Both: 1 | Unspecified:0 | Unspecified: 0 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||
86 | 148 | Sensorineural Hearing Loss Associated with Neomycin Eardrops and Nonintact Tympanic Membranes | Almut G. Winterstein, Wei Liu, Dandan Xu and Patrick J. Antonelli | pa@ufl.edu | 1999 - 2006 | Forida's Administrative claims data | SNHL - Iatrogenic | USA | Healthcare database | 1)Department of Pharmaceutical Outcome and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA 2) Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, Florida, USA 3) Department of Otolaryngology, College of Medicine, University of Florida, Gainesville, Florida, USA | Retrospective: 2 | Clinical : 2 | 134,598 | <18 years | Both: 1 | Unspecified:0 | Other:6 | non-intact tympanic membrane | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | Short-term use of neomycin eardrops in patients with NITMs is not associated with an increased risk of SNHL; however, repeated doses (ie, �2 prescriptions) showed a significant association with an increased risk of SNHL. | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||
87 | 351 | Framingham Heart Study | FHS@bu.edu | 1948 | Framingham Heart Study | Framingham in Massachusetts (US) | Population cohort | National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health and Boston University School of Medicine | Other: 4 | Cohort | Clinical : 2 | 5209 | 30-62 | Unspecified:0 | Unspecified:0 | Yes:1 | No:2 | No:2 | No:2 | No:2 | Hearing test | No:2 | Yes:1 | Blood samples | Yes:1 | ,cardiac vascular function (tonometry), echocardiogram,ECG,blood pressure, | physical examinations; height, weight, and waist, grip strength, medical history | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||
88 | 97 | Self-Reported Hearing Loss Predicts 5-Year Decline in Higher-Level Functional Capacity in High-Functioning Elderly Adults: The Fujiwara-Kyo Study | Kimiko Tomioka, MD, PhD,* Nozomi Okamoto, DDS, PhD,† Masayuki Morikawa, MD, PhD,‡ and Norio Kurumatani, MD, PhD*† | Kimiko Tomioka, Nara Prefectural Health Research Center, Nara Medical University, Shijo-cho 840, Kashihara City, Nara 6348521, Japan. E-mail: tkimiko@naramed-u.ac.jp | 2007–08 follow-up examinations in 2012-2013 | Fujiwara-Kyo Study | Dementia | Population cohort | This work was supported by Grant-in-Aid for Scientific Research 24249043 from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The authors wish to express their gratitude to all the participants for their cooperation in this study. | 3,936 | 65-93 | Both: 1 | Not stated | Unspecified:0 | Unspecified: 0 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | Yes:1 | triglycerides, LDL, HbA1c | No:2 | Yes:1 | Previous cardiac events (e.g. Mis) | Self reported HL, questionaire | Self-reported HL was found to be a significant predictor of decline in IA and SR. Preventive intervention against age-related HL may contribute to maintaining high-level functional capacity in independent elderly adults. | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||
89 | 203 | PrevalenceofHearingLossAmongChildren9to11YearsOld TheGenerationRStudy | CMP leClercq, GijsvanIngen, L Ruytjens, A Goedegebure, HA Moll, H Raat, VWV Jaddoe, RJB Jong, MP vanderSchroeff | CarlijnM.P. leClercq c.leclercq @erasmusmc.nl | 2012 - 2015 | Generation R | All - undifferentiated | Rotterdam, Netherlands | Birth Cohort | TheGenerationRStudyandDr JaddoereceivefinancialsupportfromErasmusMC Rotterdam,ErasmusUniversityRotterdam,andThe NetherlandsOrganisationforHealthResearchand Development(ZonMw). | Retrospective: 2 | Clinical : 2 | 5368 | 418 | 9-11 | Both: 1 | Majority white, grouped as white and non-white | Both:3 | SSNHL: 4 | Yes:1 | No:2 | No:2 | No:2 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | Maternal education, hx AOM | In thiscross-sectionalassessment of a population-based prospective birth cohort study, 7.8% of children were estimated to have low-orhigh-frequency SNHL in either ear, with a prevalence of 0.9% of mild or more severe SNHL (≥26dBHL). A history of re current acute otitis media and lower maternal educational status were associated with the presence of presumed SNHL. | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||
90 | 348 | Genetic Epidemiology Research on Adult Health and Aging (GERA) | info@tasciences.com | 2007 | Genetic Epidemiology Research on Adult Health and Aging (GERA) | Northern California (US) | Population cohort | Resource for Genetic Epidemiology Research in Adult Health and Aging (RC2 AG033067; Schaefer and Risch, PIs) awarded to the Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH) and the UCSF Institute for Human Genetics. The RPGEH was supported by grants from the Robert Wood Johnson Foundation, the Wayne and Gladys Valley Foundation, the Ellison Medical Foundation, Kaiser Permanente Northern California, and the Kaiser Permanente National and Northern California Community Benefit Programs. | Other: 4 | Cohort | Clinical : 2 | 140,000 | 18 and older | Unspecified:0 | Unspecified:0 | No:2 | No:2 | No:2 | No:2 | No:2 | clinical records, self reported survey | No:2 | clinical data from electronic health records(ICD-9 coded diagnoses), survey data on demographic ( gender, race/ethnicity, marital status, and education),body mass index, behavioral factors( smoking, alcohol consumption), and environmental data from various sources, | Yes:1 | Multiple, see individual study | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||||
91 | 90 | Age-related hearing decline in individuals with and without occupational noise exposure | Christina Hederstierna, Ulf Rosenhall | Dr. Christina Hederstierna, Department of Audiology and Neurotology, Karolinska University Hospital, SE-171 76 Stockholm, Sweden. E-mail: christina.forshell-hederstierna@karolinska.se | 1971 - | Gerontological and Geriatric Population Study | ARHL and NIHL | Gothenburg | Population cohort | This study was part of the Gothenburg Gerontological and Geriatric Investigation, and was supported by The Tysta Skolan Foundation and Hörselforskningsfonden. | Prospective: 1 | Clinical : 2 | 1013 | 70-75yrs | Both: 1 | Not stated | Bilateral:2 | NIHL: 5 , ARHL: 3 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||
92 | 347 | GESA project - Multi Cohort study for psychiatric diseases | Juliane Burghardt, Ana Nanette Tibubos, Danielle Otten, Elmar Brähler, Harald Binder, Hans Grabe, Johannes Kruse, Karl Heinz Ladwig, Georg Schomerus, Philipp S Wild, Manfred E Beutel | Juliane.Burghardt@uni-hamburg.de | GESA project - Multi Cohort study for psychiatric diseases | GERMANY | Population cohort | German Federal Ministry of Education and Research | Other: 4 | Cohort | Clinical : 2 | 40,000 | 20-79 | Unspecified:0 | Unspecified:0 | No:2 | No:2 | No:2 | No:2 | No:2 | Self-reported hearing assessment | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
93 | 272 | Otological diagnoses and probable age-related auditory neuropathy in “younger” and “older” elderly persons | Ulf Rosenhall, Christina Hederstierna & Esma Idrizbegovic | Ulf Rosenhall, Department of Hearing and Balance, Karolinska University Hospital Solna, SE 17176 Stockholm, Sweden. ulf.rosenhall@karolinska.se | 1901-1922 | Gothenburg Gerontological and Geriatric investigation | SNHL- ANSD | Sweden | Population cohort | The study is part of the Gothenburg Gerontological and Geriatric investigation, and it was supported by the foundation Tysta Skolan | Retrospective: 2 | clinical : 2 | 726 | 70, 75, 85 | Both: 1 | Both:3 | Cholesteatoma: 2 , ARHL: 3 , NIHL: 5 , Other:6 | Conductive HL and Mixed HL | Yes:1 | Yes:1 | No:2 | No:2 | No:2 | SiN test was monosyllabic | No:2 | No:2 | No:2 | No:2 | No:2 | The study, based on identifi able otological and audiological diagnoses in old age, showed marked differences between ‘ younger ’ (70 – 75 years) and ‘ older ’ (85 years) elderly persons. The incidence of probable age-related auditory neuropathy increased markedly from 70 – 75 year to 85 years of age. Bilateral deafness was not seen in the 70 – 75-year cohorts, only in the 85-year cohort. Conductive hearing impairments were more common in the older subgroup than in the younger one. | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||
94 | 69 | Auditory Function in 70- and 75-Year-Olds of Four Age Cohorts | R Jönsson, U Rosenhall, I Gause-Nilsson and B Steen | Radi Jo¨nsson, Department of Audiology, Sahlgrenska University Hospital, S-413 45 Go¨teborg, Sweden. (Fax. +46 31 829811) | 1922-1992 | Gottenburgh 473 elderly persons | SNHL - ARHL | Sweden | SNHL - ARHL | The studies was funded by grants from: Hjalmar Svensson’s Foundation; Ho¨rselskadades Riksfo¨rbund; the Swedish Ministry of Health and Social Affairs, Commission for Social Research; the Swedish Medical Research Council; the Go¨teborg Medical Services Administration; the Go¨teborg Administration of Social Services and Wilhelm and Martina Lundgren’s Foundation. | Prospective: 1 | Clinical : 2 | 840 | 70/75 | Both: 1 | Swedish | Unspecified:0 | ARHL: 3 | Yes:1 | Yes:1 | This cross-sectional and time-lag study of 70- and 75- year-old men and women, representative of an urban population, demonstrates a lack of consistent changes in auditory function over the past two decades. This implies that presbyacusis in elderly people living in industrialized countries is a relatively age-stable functional deficit. Hearing thresholds in the high frequency range in men, a probable sign of exposure to occupational and leisure noise, did not show any definite improvement between 1971–72 and 1992. | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
95 | 275 | Detection of deafness-causing mutations in the Greek mitochondrial genome | Haris Kokotasa, Maria Grigoriadoua, George S. Korresa, Elisabeth Ferekidoua, Dimitrios Kandilorosb, Stavros Korresc and Michael B. Petersena | Haris Kokotas, Department of Genetics, Institute of Child Health, ‘Aghia Sophia’ Children’s Hospital, Athens 11527, Greece. Tel.: +30 213 2037 333; Fax: +30 210 7700 111; hkokotas@yahoo.gr. | 1999 - 2010 | Greek 513 patients suffering from childhood onset prelingual or postlingual, bilateral, sensorineural, syndromic or non-syndromic hearing loss of any degree | SNHL - Genetic | Greece | SNHL - Undifferentiated | This study was supported in part by a grant from Oticon Fonden, Denmark (MBP) | Other: 4 | case-control | Basic Science: 1 | 513 | Both: 1 | Bilateral:2 | SNHL: 1 | Yes:1 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | No:2 | Yes:1 | MTRNR1, MTRNR1, MTTL1, MTTS1 | Childhood onset hearing impairment | 1999 - 2010 | mtDNA mutations are not a major risk factor for sensorineural deafness in the Greek population. | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||
96 | 343 | Growing Up in Scotland | PI: Paul Bradshaw | gus@scotcen.org.uk. | 2005- | Growing Up in Scotland | Scotland | Population cohort | Scottish Government | Other: 4 | Cohort | Clinical : 2 | 14,202 | all ages | Unspecified:0 | Unspecified:0 | No:2 | No:2 | No:2 | No:2 | No:2 | parent/self reported hearing | Yes:1 | Mental health, Cognitive function | No:2 | Anthropometric measurements, Lifestyle: Smoking, Physical activity, Dietary habits, Alcohol Socio-economic: Occupation, Finances, Family circumstances, Housing, Education, Ethnic group, Marital status, Social support | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||||||
97 | 339 | Gutenberg Health Study | Principal Investigator: Philipp Wild | info@ghs-mainz.de | 2007- | Gutenberg Health Study | Mainz (Germany) | Population cohort | Government of Rheinland-Pfalz , the research programs “Wissen schafft Zukunft” and “Center for Translational Vascular Biology (CTVB)” of the Johannes Gutenberg-University of Mainz, and its contract with Boehringer Ingelheim, PHILIPS Medical Systems and Novartis Pharma, including an unrestricted grant for the Gutenberg Health Study | Other: 4 | Cohort | Clinical : 2 | 15000 | 35-74 | Unspecified:0 | Unspecified:0 | No:2 | No:2 | No:2 | No:2 | No:2 | Self reported hearing assessment | Yes:1 | electrocardiogram, carotid US, echocardiography | Yes:1 | Blood , urine tests | Yes:1 | blood pressure and heart rate, | Sociodemography, medical history, cancer screening, Gender issues, Family history, children health behavior, Hobbies and leisure behavior, Smoking, secondhand smoke, alcohol consumption, Professional history, Fine dust and noise pollution, Life satisfaction and environmental factors, Home environment Medical examinations: Spirometry, Measurement of carbon monoxide in the alveolar air Tooth pocket swab - Simultaneous determination of flow-mediated vasodilation and arterial stiffness by measuring the reactivity of the brachial artery using ultrasound, volume plethysmography of the digital artery using Endo-PAT and digital photoplethysmographic pulse curve analysis - Neurocardial regulation ankle brachial index - Acquisition of the current weather data - anthropometry Ophthalmic examination - Visual quality of life - NutritionPatient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder [GAD]-7 Scale | Yes:1 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||||||
98 | 190 | Improved hearing in Swedish 70-year olds—a cohort comparison over more than four decades (1971–2014) | M Hoff, T Tengstrand, A Sadeghi, I Skoog and U Rosenhall | maria.hoff@gu.se | 1970 - unspecified | H70 framework | SNHL - ARHL | Sweden | Population cohort | This project was supported by grants from the Foundation Agneta Prytz-Folke and Gösta Folke [2013-0613]; the Foundation Tysta Skolan [2015-0601]; Göteborgs Läkaresällskap [2014-1101]; Hörselforskningsfonden [2015-484]; Region Västra Götaland [2014-0601]; Swedish Research Council [2012-5041, 2015-02830 and 2013-8717]; Swedish Research Council for Health, Working Life and Welfare [2013-1202]; AGECAP [2013-2300, 2013-2496 and 2013- 0475]; University of Gothenburg UGOT Challenge; Sahlgrenska University Hospital (ALF); Stena Foundation; Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; Swedish Alzheimer’s Foundation; Hjärnfonden; Eivind och Elsa K:son Sylvans stiftelse; Stiftelsen Söderström-Königska Sjukhemmet; Magnus Bergvalls stiftelse; Stiftelsen för Gamla Tjänarinnor; and Handlanden Hjalmar Svenssons Forskningsfond | Prospective: 1 | Clinical : 2 | 1,135 | >70 | Both: 1 | Swedish | Unspecified:0 | Unspecified:0 | Yes:1 | Yes:1 | Unspecified: cognitive examinations and interviews | No:2 | No:2 | Hearing acuity and prevalence of hearing loss in 70-year-old Swedes have improved over the last half-century. The most distinct improvements were seen in men and in the high frequencies. Although the reasons for the improvement were not investigated in this study, the nature of the findings suggests that noise-induced hearing impairment could be an important factor. The findings highlight the importance of modifiable risk factors in the prevention of ARHL | No:2 | Unknown: 0 | ||||||||||||||||||||||||||||||||||||||||||||||
99 | 277 | Genetic Characteristics in Children with Cochlear Implants and the Corresponding Auditory Performance | Chen-Chi Wu, Tien-Chen Liu, Shih-Hao Wang, Chuan-Jen Hsu, Che-Ming Wu | Chuan-Jen Hsu, MD, Department of Otolaryngology, National Taiwan University Hospital, 7 Chung-Shan S. Road, Taipei, 100, Taiwan cjhsu@ntu.edu.tw | 2002 to 2010 | Han 743 unrelated chinese children with idiopathic sensorineural hearing impairment | SNHL - Genetic | Taiwan | SNHL - Undifferentiated | This study was supported by research grants from the National Science Council of the Executive Yuan of the Republic of China (NSC- 97-2314-B-002-092-MY3) and National Taiwan University Hospital (NTUH-098- 001156). | Other: 4 | case-control | clinical : 2 | 743 | 7.1 6 4.8 | Both: 1 | Han Chinese | Unspecified:0 | SNHL: 1 | yes:1 | Categories of Auditory Performance Scores (CAP) | No:2 | Yes:1 | High Resolution Temporal Bone CT +/- MRI | No:2 | No:2 | No:2 | No:2 | Yes:1 | GJB2, SLC26A4, 12S rRNA, OTOF | idiopathic SNHL | 2002 - 2010 | A significant prevalence of genetic mutations was identified in children with CIs, suggesting the need for routine genetic assessments. The frequencies of common deafness-associated mutations were different between children with and without CIs. The presence of genetic mutations was associated with an excellent long-term auditory performance outcome after implantation | No:2 | Unknown: 0 | |||||||||||||||||||||||||||||||||||||
100 | 7 | Prevalence and range of GJB2 and SLC26A4 mutations in patients with autosomal recessive non‐syndromic hearing loss | H. Jiang, J. Chen, X. Shan, Y. Li, J. He, B. Yang | yangbb1959@sina.com | Unspecified | Hangzhou 176 unrelated pediatric patients with ARNH | SNHL - Genetic | China | SNHL - Genetic/Hereditary | Prospective: 1 | Basic Science: 1 | 176 | 5 | 9y - 18 | Both: 1 | Chinese | Bilateral:2 | SNHL: 1 | Yes:1 | Yes:1 | Yes:1 | Yes:1 | Yes:1 | CT temporal bones | Yes:1 | GJB2, SLC26A4, GJB3 | ARNHL | No:2 | Unknown: 0 |